Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG)
Lead Research Organisation:
London School of Hygiene & Tropical Medicine
Department Name: Epidemiology and Population Health
Abstract
The mission of the MRC Tropical Epidemiology Group (TEG) is to help improve health in low- and middle-income countries (LMICs), by conducting research that identifies and evaluates effective interventions.
Infectious diseases, including malaria, HIV, tuberculosis (TB) and neglected tropical diseases (NTDs), remain a main focus of our research, as they are the leading causes of ill-health in Africa. In the next grant period, we will expand our research on emerging diseases, adolescent health and non-communicable diseases - particularly hypertension, diabetes and chronic obstructive pulmonary disease, which are major disease problems in LMICs. Our research focuses on conditions that are major causes of ill-health, and for which improved prevention or treatment leads directly to improved economic and social outcomes. The importance of these issues to the UK is highlighted in the 2015 Government strategy for overseas aid, on tackling global challenges in the national interest.
The scale-up of malaria control tools, primarily long-lasting insecticidal nets, and effective combination therapies, has prevented an estimated 663 million clinical malaria cases in sub-Saharan Africa since 2000, and has made malaria elimination an achievable goal in some countries. However, these gains may be threatened by insecticide resistance, drug-resistance, and resource-constraints. Within the next grant period, our focus will be on evaluating new tools, combining new and existing control strategies, and investigating sustainable and more effective deployment of these strategies.
For HIV, we focus on the goal that 90% of those living with HIV know their status, 90% of known HIV-positive individuals receive sustained ART, and 90% of individuals on ART have durable viral suppression. For example, we are leading a major trial in South Africa and Zambia to evaluate the impact of a combination prevention intervention on new cases of HIV in the community. The intervention includes household-based HIV testing and linkage-to-health services by community care providers, and immediate initiation of treatment delivered through routine healthcare services.
TEG research on TB includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved TB case finding and prevention, and evaluation of structural interventions (social support and monetary incentives) to control TB. For example, we are working on a trial to evaluate an improved electronic medication device for TB patients to reduce treatment failure and subsequent recurrence/retreatment in the absence of directly observed treatment.
We will continue our long-standing work on intervention strategies for the control and elimination of NTDs, and our more recent involvement in the control of outbreaks such as the Ebola and Zika virus outbreaks. We will also continue our work on the effectiveness of lay-health worker interventions to treat common mental disorders (depression and anxiety), focusing particularly on treatment of these conditions among adolescents, in whom over half of mental health disorders start.
Through the MRC Programme Grant, we leverage additional funding for research projects and support salaries for around 30 statisticians and epidemiologists, based at LSHTM. The grant is critical to enable us to recruit and retain these scientists, who have disease and methodological expertise in the design and analysis of epidemiological studies in LMICs. We collaborate with the MRC Units in The Gambia and Uganda, and over 50 other research institutes in LMICs. We will continue our initiatives to increase capacity in medical statistics in sub-Saharan Africa, for example by expanding the MRC TEG Fellowship scheme, which to date has trained 17 medical statisticians through a Masters in Medical Statistics at LSHTM, followed by a placement year. All are now working as medical statisticians in Africa.
Infectious diseases, including malaria, HIV, tuberculosis (TB) and neglected tropical diseases (NTDs), remain a main focus of our research, as they are the leading causes of ill-health in Africa. In the next grant period, we will expand our research on emerging diseases, adolescent health and non-communicable diseases - particularly hypertension, diabetes and chronic obstructive pulmonary disease, which are major disease problems in LMICs. Our research focuses on conditions that are major causes of ill-health, and for which improved prevention or treatment leads directly to improved economic and social outcomes. The importance of these issues to the UK is highlighted in the 2015 Government strategy for overseas aid, on tackling global challenges in the national interest.
The scale-up of malaria control tools, primarily long-lasting insecticidal nets, and effective combination therapies, has prevented an estimated 663 million clinical malaria cases in sub-Saharan Africa since 2000, and has made malaria elimination an achievable goal in some countries. However, these gains may be threatened by insecticide resistance, drug-resistance, and resource-constraints. Within the next grant period, our focus will be on evaluating new tools, combining new and existing control strategies, and investigating sustainable and more effective deployment of these strategies.
For HIV, we focus on the goal that 90% of those living with HIV know their status, 90% of known HIV-positive individuals receive sustained ART, and 90% of individuals on ART have durable viral suppression. For example, we are leading a major trial in South Africa and Zambia to evaluate the impact of a combination prevention intervention on new cases of HIV in the community. The intervention includes household-based HIV testing and linkage-to-health services by community care providers, and immediate initiation of treatment delivered through routine healthcare services.
TEG research on TB includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved TB case finding and prevention, and evaluation of structural interventions (social support and monetary incentives) to control TB. For example, we are working on a trial to evaluate an improved electronic medication device for TB patients to reduce treatment failure and subsequent recurrence/retreatment in the absence of directly observed treatment.
We will continue our long-standing work on intervention strategies for the control and elimination of NTDs, and our more recent involvement in the control of outbreaks such as the Ebola and Zika virus outbreaks. We will also continue our work on the effectiveness of lay-health worker interventions to treat common mental disorders (depression and anxiety), focusing particularly on treatment of these conditions among adolescents, in whom over half of mental health disorders start.
Through the MRC Programme Grant, we leverage additional funding for research projects and support salaries for around 30 statisticians and epidemiologists, based at LSHTM. The grant is critical to enable us to recruit and retain these scientists, who have disease and methodological expertise in the design and analysis of epidemiological studies in LMICs. We collaborate with the MRC Units in The Gambia and Uganda, and over 50 other research institutes in LMICs. We will continue our initiatives to increase capacity in medical statistics in sub-Saharan Africa, for example by expanding the MRC TEG Fellowship scheme, which to date has trained 17 medical statisticians through a Masters in Medical Statistics at LSHTM, followed by a placement year. All are now working as medical statisticians in Africa.
Technical Summary
The aim of TEG is to conduct cutting-edge epidemiological studies on health problems of low- and middle-income countries (LMICs). TEG will continue to have a major focus on the epidemiology and control of infectious diseases, with increased emphasis on evaluating delivery strategies for interventions of proven effectiveness. We will expand our research on emerging infectious diseases, adolescent health, non-communicable diseases and applied epidemiological methods. We will also expand our capacity building initiatives, including the TEG Fellowship scheme to train African statisticians. These issues are critical to the UK Government strategy for overseas aid, as indicated by the £1.5 billion Global Challenges Research Fund to support challenges in LMICs.
TEG malaria research includes assessing the scale-up and combination of malaria control tools, e.g. investigating sustainable and more effective deployment of long-lasting insecticidal nets, and effective combination therapies. For HIV, we focus on community-based approaches to improving HIV testing and linkage-to-care in sub-Saharan Africa, and interventions for key populations in high-incidence settings. Our TB research includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved case finding and prevention, and structural interventions. We will continue research on the control and elimination of NTDs, including the Ebola and Zika virus outbreaks. Finally, we conduct applied methodological work to advance the design and analysis of epidemiological studies in LMICs.
Through the Programme Grant, we will continue to leverage funding to recruit and retain a critical mass of scientists who have expertise in design and analysis of epidemiological studies in LMICs, and relevant disease-specific expertise. We collaborate closely with the African MRC Units and many other institutes in LMICs, with whom we published 700 papers in the past 5 year
TEG malaria research includes assessing the scale-up and combination of malaria control tools, e.g. investigating sustainable and more effective deployment of long-lasting insecticidal nets, and effective combination therapies. For HIV, we focus on community-based approaches to improving HIV testing and linkage-to-care in sub-Saharan Africa, and interventions for key populations in high-incidence settings. Our TB research includes studies to evaluate improved TB treatment strategies, improved diagnosis, prevention and control of drug-resistant TB, improved case finding and prevention, and structural interventions. We will continue research on the control and elimination of NTDs, including the Ebola and Zika virus outbreaks. Finally, we conduct applied methodological work to advance the design and analysis of epidemiological studies in LMICs.
Through the Programme Grant, we will continue to leverage funding to recruit and retain a critical mass of scientists who have expertise in design and analysis of epidemiological studies in LMICs, and relevant disease-specific expertise. We collaborate closely with the African MRC Units and many other institutes in LMICs, with whom we published 700 papers in the past 5 year
Planned Impact
Beneficiaries of our research include i) populations in low- and middle-income countries (LMICs) affected by the diseases which we research, ii) local and national stakeholders; iii) national and international policy makers; iv) scientists within TEG; v) our collaborators in LMICs; and vi) the wider academic community of global health researchers.
i) The diseases we focus on are malaria, HIV, TB, emerging and neglected diseases - including mental health, eye health and non-communicable diseases. Each of these disproportionately affect the poorest in resource-poor countries, and those marginalised from society. These diseases also have a substantial impact on national socio-economic development. By reducing the rates of important causes of ill health, we have the potential to alleviate poverty as well as improving life expectancy. Many of the studies we undertake involve community-based interventions focused on overcoming barriers to health service access and to minimize stigma and discrimination. This is a common issue for many of the diseases we work on, and particularly for HIV and mental health, and among some of the key populations that we focus on, including adolescents and high-risk groups.
ii) We engage with local and national stakeholders, as described in the Pathways to Impact statement, and they benefit directly, for example, from our studies to evaluate optimal strategies for delivery of interventions of known effectiveness (for example on integrating HIV and non-communicable disease treatment and care); or to improve efficiency or cost of interventions (for example the first trial of reduced dose human papillomavirus (HPV) vaccine in Tanzania, or the planned trial of fractional dose pneumococcal vaccine in Kenya).
iii) We are able to ensure that results from our research and other important studies help to inform new policies and guidelines, through our role on national and international advisory committees, including as Chair of the WHO Joint Technical Expert Group on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond; and members of the UNAIDS Scientific Expert Panel, the scientific advisory committees of EDCTP and CEPI (Coalition for Epidemic Preparedness, Innovations), the WHO Technical Advisory Committee on Safe Male Circumcision, the WHO Evidence Review Group on Malaria in Pregnancy, the WHO Global Malaria Programme, Surveillance Monitoring and Evaluation Technical Advisory Group, and WHO Expert Working Groups on Lassa fever, Nipah virus and MERS Co-V vaccine Target Product Profiles.
iv) The Programme Grant enables us to sustain a strong critical mass of experienced statistical epidemiologists and to provide an actively supportive academic environment and mentorship for all our staff. We regularly review and encourage career development, support the development of Fellowship and research grant applications, and provide funds for training courses and conference attendance.
v) Our collaborators benefit directly from our research (see Letters of Support), as the Programme Grant enables us to provide consistent and continuous, disease-specific, statistical and epidemiological expertise that is in short supply in global health research. This leads to high-quality scientific outputs and new grant applications, which lead to population health benefits. We also have an impact on the careers of the MSc, PhD and post-doctoral students who we teach, supervise and mentor, both at LSHTM, through our Fellowship scheme and collaborative links, as described in the Case for Support and Academic Beneficiaries sections.
vi) We produce around 120 papers annually, and disseminate findings at international conferences in order to benefit to the wider academic community working on global health. This includes clinical epidemiologists, social scientists and laboratory scientists. In March 2021 we plan to hold a two-day symposium to increase the impact and reach of our research findings.
i) The diseases we focus on are malaria, HIV, TB, emerging and neglected diseases - including mental health, eye health and non-communicable diseases. Each of these disproportionately affect the poorest in resource-poor countries, and those marginalised from society. These diseases also have a substantial impact on national socio-economic development. By reducing the rates of important causes of ill health, we have the potential to alleviate poverty as well as improving life expectancy. Many of the studies we undertake involve community-based interventions focused on overcoming barriers to health service access and to minimize stigma and discrimination. This is a common issue for many of the diseases we work on, and particularly for HIV and mental health, and among some of the key populations that we focus on, including adolescents and high-risk groups.
ii) We engage with local and national stakeholders, as described in the Pathways to Impact statement, and they benefit directly, for example, from our studies to evaluate optimal strategies for delivery of interventions of known effectiveness (for example on integrating HIV and non-communicable disease treatment and care); or to improve efficiency or cost of interventions (for example the first trial of reduced dose human papillomavirus (HPV) vaccine in Tanzania, or the planned trial of fractional dose pneumococcal vaccine in Kenya).
iii) We are able to ensure that results from our research and other important studies help to inform new policies and guidelines, through our role on national and international advisory committees, including as Chair of the WHO Joint Technical Expert Group on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond; and members of the UNAIDS Scientific Expert Panel, the scientific advisory committees of EDCTP and CEPI (Coalition for Epidemic Preparedness, Innovations), the WHO Technical Advisory Committee on Safe Male Circumcision, the WHO Evidence Review Group on Malaria in Pregnancy, the WHO Global Malaria Programme, Surveillance Monitoring and Evaluation Technical Advisory Group, and WHO Expert Working Groups on Lassa fever, Nipah virus and MERS Co-V vaccine Target Product Profiles.
iv) The Programme Grant enables us to sustain a strong critical mass of experienced statistical epidemiologists and to provide an actively supportive academic environment and mentorship for all our staff. We regularly review and encourage career development, support the development of Fellowship and research grant applications, and provide funds for training courses and conference attendance.
v) Our collaborators benefit directly from our research (see Letters of Support), as the Programme Grant enables us to provide consistent and continuous, disease-specific, statistical and epidemiological expertise that is in short supply in global health research. This leads to high-quality scientific outputs and new grant applications, which lead to population health benefits. We also have an impact on the careers of the MSc, PhD and post-doctoral students who we teach, supervise and mentor, both at LSHTM, through our Fellowship scheme and collaborative links, as described in the Case for Support and Academic Beneficiaries sections.
vi) We produce around 120 papers annually, and disseminate findings at international conferences in order to benefit to the wider academic community working on global health. This includes clinical epidemiologists, social scientists and laboratory scientists. In March 2021 we plan to hold a two-day symposium to increase the impact and reach of our research findings.
Organisations
- London School of Hygiene & Tropical Medicine (Lead Research Organisation)
- Sophia University Japan (Collaboration)
- Liverpool School of Tropical Medicine (Collaboration)
- Rwanda Biomedical Center (Collaboration)
- Baylor College of Medicine (Collaboration)
- University of KwaZulu-Natal (Collaboration)
- Africa Centres for Disease Control and Prevention (Collaboration)
- Kilimanjaro Christian Medical University College (Collaboration)
- Malaria Consortium (Collaboration)
- National Institute for Medical Research, Tanzania (Collaboration)
- Johns Hopkins University (Collaboration)
- Royal Veterinary College (RVC) (Collaboration)
- UNIVERSITY OF BIRMINGHAM (Collaboration)
- Desmond Tutu HIV Foundation (Collaboration)
- CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST (Collaboration)
- MRC/UVRI Uganda Research Unit on AIDS (Collaboration)
- Medical Research Council (MRC) (Collaboration)
- Francis Crick Institute (Collaboration)
- Centre for Research in Infectious Diseases (CRID) (Collaboration)
- University of Copenhagen (Collaboration)
- Burnet Institute (Collaboration)
- University of Makeni (Collaboration)
- University of East Anglia (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- KNCV Tuberculosis Foundation (Collaboration)
- Ipsos MORI (Collaboration)
- SIMAD University (Collaboration)
- Mahidol University (Collaboration)
- Tufts University (Collaboration)
- UNIVERSITY OF PRETORIA (Collaboration)
- François Rabelais University or University of Tours (Collaboration)
- University Cheikh Anta Diop de Dakar (Collaboration)
- KING'S COLLEGE LONDON (Collaboration)
- University of Abomey-Calavi (Collaboration)
- Medicines for Malaria Venture (MMV) (Collaboration)
- Hiwot Fana Hospital (Collaboration)
- Kilimanjaro Christian Medical Centre (KCMS) (Collaboration)
- University of Accra (Collaboration)
- ST GEORGE'S UNIVERSITY OF LONDON (Collaboration)
- HealthRight International (Collaboration)
- University of Lusaka (Collaboration)
- International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) (Collaboration)
- QUEEN MARY UNIVERSITY OF LONDON (Collaboration)
- Kenyan Institute for Medical Research (KEMRI) (Collaboration)
- Kintampo Health Research Centre (Collaboration)
- Sangath (Collaboration)
- Zambart (Collaboration)
- University of Bristol (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- HARAMAYA UNIVERSITY (Collaboration)
- University of Sussex (Collaboration)
- Aga Khan University (Collaboration)
- Kamuzu Central Hospital (Collaboration)
- UNIVERSITY OF GHANA (Collaboration)
- Armauer Hansen Research Institute (Collaboration)
- Tulane University (Collaboration)
- Christian Medical College, Vellore (Collaboration)
- Pasteur Institute of Madagascar (Collaboration)
- Nigeria Institute of Medical Research (Collaboration)
- Heidelberg University (Collaboration)
- WoMena, Uganda (Collaboration)
- National Health Laboratory (Collaboration)
- Swiss Tropical & Public Health Institute (Collaboration)
- Centro de Investigação em Saúde de Manhiça (Collaboration)
- University of Ottawa (Collaboration)
- University of Bamako (Collaboration)
- UNIVERSITY OF JOS (Collaboration)
- Institut Pierre Richet (IPR) (Collaboration)
- The SHM Foundation (Collaboration)
- Leiden University Medical Center (Collaboration)
- University Medical Center Utrecht (UMC) (Collaboration)
- Cote D'Ivoire's National Institute of Public Health (Collaboration)
- University of Ibadan (Collaboration)
- HARVARD UNIVERSITY (Collaboration)
- Texas Children's Hospital (Collaboration)
- African Population and Health Research Center (Collaboration)
- National Institute of Health and Medical Research (INSERM) (Collaboration)
- Wellcome Trust (Collaboration)
- Partners In Health (Collaboration)
- University of Zimbabwe (Collaboration)
- Biomedical Research and Training Institute (BRTI) (Collaboration)
- Mahosot Hospital (Collaboration)
- Monash University (Collaboration)
- University of Malawi (Collaboration)
- UNICEF (Collaboration)
- National Center for Scientific and Technological Research (CNRST) (Collaboration)
- Government of Zimbabwe (Collaboration)
- MOI UNIVERSITY (Collaboration)
- Stellenbosch University (Collaboration)
- University of the Witwatersrand (Collaboration)
- Njala University, Sierra Leone (Collaboration)
- Ifakara Health Institute (Collaboration)
- National Hospital of Pneumo-Phtisiology (Collaboration)
- University of Cape Town (Collaboration)
- UNIVERSITY OF NAIROBI (Collaboration)
- Organization for Public Health Interventions and Development (Collaboration)
- Universidade de São Paulo (Collaboration)
- World Health Organization (WHO) (Collaboration)
- University College London (Collaboration)
- McGill University (Collaboration)
- National University of Kyiv Mohyla Academy (Collaboration)
- Government of The Gambia (Collaboration)
- Ministry of Health, Uganda (Collaboration)
- University of Bordeaux (Collaboration)
- Ministry of Health and Child Welfare of the Republic of Zimbabwe (Collaboration)
- Peekvsion (Collaboration)
- Fred Hutchinson Cancer Research Center (FHCRC) (Collaboration)
- Africa Health Research Institute (Collaboration)
- Pasteur Institute, Morocco (Collaboration)
Publications
Abaasa A
(2019)
Use of reliable contraceptives and its correlates among women participating in Simulated HIV vaccine efficacy trials in key-populations in Uganda.
in Scientific reports
Abatan B
(2021)
Intense and Mild First Epidemic Wave of Coronavirus Disease, The Gambia
in Emerging Infectious Diseases
Abotsi RE
(2022)
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease.
in ERJ open research
Abotsi RE
(2021)
Prevalence and antimicrobial resistance profiles of respiratory microbial flora in African children with HIV-associated chronic lung disease.
in BMC infectious diseases
| Title | Additional file 1 of Effect of roof colour on indoor temperature and human comfort levels, with implications for malaria control: a pilot study using experimental houses in rural Gambia |
| Description | Additional file 1: Figure S1. Outdoor temperature and humidity during the study. Grey = bare metal roofs, red = red roof and white = white roof. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2021 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_1_of_Effect_of_roof_colour_on_in... |
| Title | Additional file 1 of Effect of roof colour on indoor temperature and human comfort levels, with implications for malaria control: a pilot study using experimental houses in rural Gambia |
| Description | Additional file 1: Figure S1. Outdoor temperature and humidity during the study. Grey = bare metal roofs, red = red roof and white = white roof. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2021 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_1_of_Effect_of_roof_colour_on_in... |
| Title | Additional file 1 of Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa |
| Description | Additional file 1 Fig. A1. Distribution IFN-gamma results among 57 household contacts who developed tuberculosis during follow-up. * The most recently available QFT test result prior to TB diagnosis was used. For n = 40 contacts who developed TB between V1-V2, this was QFT test result at visit 1. For n = 17 contacts who developed TB between V2-V3, this was QFT test result at visit 2 (n = 12), or at visit 1 when visit 2 QFT test result was missing (n = 5). ** Histogram was plotted among both HIV negative and HIV positive household contacts. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2020 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_1_of_Interpretation_of_serial_in... |
| Title | Additional file 1 of Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa |
| Description | Additional file 1 Fig. A1. Distribution IFN-gamma results among 57 household contacts who developed tuberculosis during follow-up. * The most recently available QFT test result prior to TB diagnosis was used. For n = 40 contacts who developed TB between V1-V2, this was QFT test result at visit 1. For n = 17 contacts who developed TB between V2-V3, this was QFT test result at visit 2 (n = 12), or at visit 1 when visit 2 QFT test result was missing (n = 5). ** Histogram was plotted among both HIV negative and HIV positive household contacts. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2020 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_1_of_Interpretation_of_serial_in... |
| Title | Additional file 2 of Effect of roof colour on indoor temperature and human comfort levels, with implications for malaria control: a pilot study using experimental houses in rural Gambia |
| Description | Additional file 2: Figure S2. Aerial view showing different roof colours in Tanzania © Jakob B. Knudsen. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2021 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_2_of_Effect_of_roof_colour_on_in... |
| Title | Additional file 2 of Effect of roof colour on indoor temperature and human comfort levels, with implications for malaria control: a pilot study using experimental houses in rural Gambia |
| Description | Additional file 2: Figure S2. Aerial view showing different roof colours in Tanzania © Jakob B. Knudsen. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2021 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_2_of_Effect_of_roof_colour_on_in... |
| Title | Additional file 2 of Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa |
| Description | Additional file 2 Fig. A2. Distribution IFN-gamma results among 1165 household contacts who did not develop tuberculosis during follow-up. * QFT test result at visit 1 was used for the 1165 contacts who did not develop TB during follow-up. ** Histogram was plotted among both HIV negative and HIV positive household contacts |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2020 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_2_of_Interpretation_of_serial_in... |
| Title | Additional file 2 of Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa |
| Description | Additional file 2 Fig. A2. Distribution IFN-gamma results among 1165 household contacts who did not develop tuberculosis during follow-up. * QFT test result at visit 1 was used for the 1165 contacts who did not develop TB during follow-up. ** Histogram was plotted among both HIV negative and HIV positive household contacts |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2020 |
| URL | https://springernature.figshare.com/articles/figure/Additional_file_2_of_Interpretation_of_serial_in... |
| Title | CHIEDZA study film |
| Description | 9 minute film about the CHIIEDZA trial |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2021 |
| Impact | None yet |
| URL | https://www.youtube.com/watch?v=BmTNqBFDB-8&t=186s |
| Title | STAMP film |
| Description | An 8 minute film describing the STAMP trial. Clinical trial coordinators and research staff recruiting and following-up patients and laboratory staff, and the international trial coordinator were interviewed. |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2018 |
| Impact | Film shown at the Steve Lawn Memorial lecture, March 2018. Over 200 views https://www.youtube.com/watch?v=CoP5GIfiMe8&t=1s [full version] https://www.youtube.com/watch?v=LYHEFQsE7HE&t=12s [social media version] |
| URL | https://www.youtube.com/watch?v=CoP5GIfiMe8&t=1s |
| Title | Taura |
| Description | Dance and drama performance by young people, created through the Art of Health competition in Zimbabwe |
| Type Of Art | Performance (Music, Dance, Drama, etc) |
| Year Produced | 2022 |
| Impact | Performed at REPS Theatre in Harare, Bulawayo Theatre and University of Zimbabwe |
| Description | B-Gap |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| Impact | It is now easier, quicker, cheaper and less intrusive for parents to get their children tested for HIV |
| Description | Chair of WHO |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Chair of WHO |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | May lead to the more rapid introduction of RSV vaccines in LMICs. |
| Description | Chair of WHO SAGE Working Group on malaria vaccines |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Chair of WHO SAGE Working Group on the RTS,S/AS01 malaria vaccine |
| Geographic Reach | Africa |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Evidence review group leading too WHO recommendation on the use of the first vaccine against malaria |
| URL | https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-on-who-r... |
| Description | Contribution to UNAIDS Briefing Document on UTT |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in other policy documents |
| URL | https://www.unaids.org/en/resources/documents/2021/universal-test-and-connect-brief-considerations |
| Description | Design of treatment trials for 2019-nCoV cases (PS, TE) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Should identify more rapidly increases in survival and quality of life |
| Description | EDCTP Scientific Advisory Committee |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Advice on research programme of EDCTP on interventions against diseases of poverty in Africa |
| URL | https://www.edctp.org/about-us/scientific-advisory-committee/ |
| Description | HPV vaccine single dose |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| Impact | the UK JCVI has recommended that UK moves to a single dose of HPV vaccine for girls & boys aged <15 years |
| URL | https://www.gov.uk/government/publications/single-dose-of-hpv-vaccine-jcvi-interim-advice |
| Description | Inclusion of seasonal vaccination trial paper and secondary analyses in background paper for RTS,S vaccine policy decision |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | Cited in background papers for evidence review group leading to WHO recommendation on the use of the first vaccine against malaria |
| URL | https://cdn.who.int/media/docs/default-source/immunization/mvip/full-evidence-report-on-the-rtss-as0... |
| Description | MVIP-Programme Advisory Group Meeting |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | The idea of this meeting is inform a decision on routine use of the RTS,S malaria vaccine for the first time, so could lead to increases in survival, quality of life, decreases in (malaria) incidence across sub-saharan Africa. The influence of our trial which is feeding into this will mainly relate to West Africa. |
| Description | PopART and policy for HIV testing and treatment |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Impact | Trial findings have informed design and delivery of HIV testing services in S Africa and WHO deliberations on implementation of universal testing and treatment |
| URL | http://hivst.org/policy/zambia |
| Description | Prioritisation of 2019-nCoV vaccines (PS) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Membership of a guideline committee |
| Impact | Should identify more rapidly increases in survival and quality of life |
| Description | R21 malaria vaccine |
| Geographic Reach | Africa |
| Policy Influence Type | Citation in other policy documents |
| Description | STAMP - Article in Aidsmap following publication of CID paper |
| Geographic Reach | Africa |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| URL | http://www.aidsmap.com/news/feb-2020/alarmingly-high-mortality-hospitalised-patients-hivtb-co-infect... |
| Description | STAMP - TAG |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
| URL | http://www.treatmentactiongroup.org/content/activists-call-countries-and-donors-immediately-scale-us... |
| Guideline Title | The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV |
| Description | STAMP - preparatory work to trial cited in WHO 2019 LAM policy update |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.who.int/tb/publications/use-of-lf-lam-tb-hiv/en/ |
| Guideline Title | WHO bed net procurement for endemic countries |
| Description | Trial results fed into guidelines for WHO re. bed net procurement for endemic countries |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Impact | The WHO guidelines have been updated to recommend the net type that we trialled in our work in West Africa. This will enable country programmes to procure these nets using donar funding |
| URL | https://www.who.int/publications/i/item/guidelines-for-malaria |
| Description | UK Government Period Poverty Taskforce |
| Geographic Reach | National |
| Policy Influence Type | Membership of a guideline committee |
| URL | https://www.gov.uk/government/news/period-poverty-taskforce-minister-announces-next-steps-on-menstru... |
| Description | VCAG |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Evaluation of vector control interventions. |
| URL | https://www.who.int/groups/vector-control-advisory-group/about |
| Description | VCAG |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Evaluation of vector control inverventions |
| URL | https://www.who.int/groups/vector-control-advisory-group/about |
| Description | WHO Committee to develop a framework for the allocation of limited supplies of malaria vaccine |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Advice on how to deploy limited suppies of the RTS,S/AS01 malria vaccine for greatest public health impact |
| URL | https://cdn.who.int/media/docs/default-source/immunization/mvip/framework_for_policy_decision_on_rts... |
| Description | WHO DAT Task Force |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | It's a relatively new group so not an opportunity to influence on policy, practice, patients or the public - but will do so in the future |
| Description | WHO HIV-VL |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | None yet |
| Description | WHO Technical Advisory Group |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Evaluates intervention to reduce malaria mortality in Africa. |
| Description | WHO Technical Advisory Group on the effectiveness of rectal artesunate for pre-referal treatment of severe malaria |
| Geographic Reach | Africa |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | Evaluates intervention to reduce malaria mortality in Africa |
| Description | WHO Technical Consultation on Chemoprevention (MC) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | May lead to more flexible recommendations on chemopreventive approaches allowing its use in a wider area and/or subsequent policy changes |
| Description | WHO Technical Consultation on SMC (MC) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Impact | May lead to more flexible recommendations on SMC allowing its use in a wider area and/or subsequent policy changes |
| Description | WHO working group |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | WHO working group to develop a roadmap for global introduction of new tuberculosis vaccines |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | (RPC): FILLING THE GAPS IN EVIDENCE: BUILDING STRONGER AND MORE RESILIENT HEALTH SYSTEMS - RAFT |
| Amount | £7,812,831 (GBP) |
| Organisation | UK Department for International Development |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 04/2026 |
| Description | Academy of Medical Sciences |
| Amount | £24,982 (GBP) |
| Funding ID | GCRFNGR7 |
| Organisation | United Kingdom Research and Innovation |
| Department | Global Challenges Research Fund |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2021 |
| End | 06/2022 |
| Description | Africa CDC - LSHTM MRC International Statistics & Epidemiology Group Partnership to Support Robust Analysis of COVID-19 Seroprevalence Data in Africa |
| Amount | £59,551 (GBP) |
| Funding ID | MR/W022397/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2021 |
| End | 02/2022 |
| Description | AlCohol use in HumanitariAN settings: a programme of work to address alcohol and associated adversities among conflict-affected populations in UGanda and UkrainE (CHANGE) |
| Amount | £3,803,801 (GBP) |
| Funding ID | 219468/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 04/2025 |
| Description | Attractant Targeted Sugar Bates (ATSB) trial |
| Amount | $6,499,963 (USD) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 04/2021 |
| Description | Bioko 2022 |
| Amount | $55,834 (USD) |
| Organisation | Medical Care Development International (MCDI) |
| Sector | Private |
| Country | United States |
| Start | 01/2022 |
| End | 12/2022 |
| Description | Building a sustainable model to promote menstrual, sexual and reproductive health (MSRH) amongst secondary school girls in Tanzania |
| Amount | £676,305 (GBP) |
| Funding ID | MR/T040297/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 05/2024 |
| Description | CEASE |
| Amount | £56,169 (GBP) |
| Funding ID | SC_ROC08901400MDMD |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2021 |
| End | 12/2024 |
| Description | Combination prevention and strategies for HIV control: In-depth analysis of data from the HPTN 071 (PopART) trial |
| Amount | $1,198,185 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2020 |
| End | 01/2022 |
| Description | Community Blood Pressure Groups - developing an intervention to improve blood pressure control in Zimbabwe |
| Amount | £154,730 (GBP) |
| Funding ID | MR/Y503198/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 05/2023 |
| End | 11/2024 |
| Description | Cross-sectional survey to measure additional outcomes for the HPTN 071 (PopART study) |
| Amount | $700,000 (USD) |
| Organisation | International Initiative for Impact Evaluation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 07/2019 |
| End | 10/2020 |
| Description | Crowdsourcing with adolescents in Senegal |
| Amount | £323,754 (GBP) |
| Funding ID | MR/S023712/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2019 |
| End | 08/2021 |
| Description | DREAMM |
| Amount | £24,225 (GBP) |
| Funding ID | DRIA2014-314 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 04/2021 |
| End | 12/2021 |
| Description | DfID - SUCCEED (SUpport, Comprehensive Care and EmpowErment for people with psychosocial Disabilities in Sub-Saharan Africa) |
| Amount | £56,510 (GBP) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 04/2025 |
| Description | Early Career Award, 'Significance of Hypertension in Early Adulthood Research (SHEAR) |
| Amount | £1,185,342 (GBP) |
| Funding ID | 227647/Z/23/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 04/2024 |
| End | 04/2027 |
| Description | East and Southern African Consortium for Outbreak Epidemiology Training (ENTRANT) Fellowships |
| Amount | £619,832 (GBP) |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 03/2021 |
| End | 03/2024 |
| Description | Effects of metronidazole plus intermittent preventive treatment of malaria in pregnancy on birth outcomes: a randomised controlled trial in Zambia |
| Amount | £2,695,764 (GBP) |
| Funding ID | MR/S004998/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2018 |
| End | 10/2023 |
| Description | Evaluation of the effectiveness of integrated vector control management on the incidence of Aedes-borne diseases in Malaysia: A Cluster Randomized Controlled Trial |
| Amount | € 3,854,390 (EUR) |
| Organisation | Bayer |
| Sector | Private |
| Country | Germany |
| Start | 05/2020 |
| End | 12/2022 |
| Description | GF CdI trial 002 |
| Amount | $4,105,563 (USD) |
| Organisation | Global Fund to Fight AIDS, Tuberculosis and Malaria |
| Sector | Charity/Non Profit |
| Country | Switzerland |
| Start | 11/2022 |
| End | 12/2024 |
| Description | Genital InFlammation Test (GIFT) for HIV prevention and reproductive health: point-of-care cytokine biomarker lateral flow test for asymptomatic inflammatory sexually transmitted infections (STIs) and bacterial vaginosis (BV |
| Amount | € 3,508,462 (EUR) |
| Funding ID | RIA2020I-3297 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 03/2021 |
| End | 03/2024 |
| Description | How do early-life infectious and nutritional exposures characteristic of tropical Africa impact subsequent cardiovascular disease risk? |
| Amount | £1,134,893 (GBP) |
| Funding ID | MR/Y013948/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2024 |
| End | 02/2027 |
| Description | Human infection studies for Schistosoma mansoni vaccine testing in Uganda |
| Amount | £640,968 (GBP) |
| Funding ID | 218454/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2020 |
| End | 05/2025 |
| Description | INTREPID (International Research Programme on Psychoses in Diverse Settings) III: Deepening and Broadening Knowledge of Psychoses Globally |
| Amount | £3,211,811 (GBP) |
| Funding ID | MR/X022242/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 06/2023 |
| End | 06/2028 |
| Description | Insecticide treated eave nets and window screens for malaria control |
| Amount | £212,405 (GBP) |
| Funding ID | MR/T003677/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 06/2021 |
| Description | LSHTM COVID-19 Response Fund |
| Amount | £18,080 (GBP) |
| Funding ID | DONAT15915 |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 06/2021 |
| End | 04/2022 |
| Description | Laboratory Insecticide Testing |
| Amount | £535,435 (GBP) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 03/2022 |
| End | 02/2025 |
| Description | MOBILE MEN |
| Amount | € 466,519,250 (EUR) |
| Funding ID | 101103140 - MOBILE MEN - HORIZON-JU-GH-EDCTP3-2022-01 HE |
| Organisation | European Commission |
| Sector | Public |
| Country | European Union (EU) |
| Start | 06/2023 |
| End | 06/2026 |
| Description | MRC International Statistics & Epidemiology Partnership (ISEP): Strengthening capacity in applied medical statisticians in sub-Saharan Africa |
| Amount | £2,643,791 (GBP) |
| Funding ID | MR/X019888/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2024 |
| End | 10/2028 |
| Description | MRC PHIND - Improving management of self-reported abnormal vaginal discharge in rural north India |
| Amount | £150,000 (GBP) |
| Funding ID | MR/T026979/1 |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 06/2022 |
| Description | Male partner-assisted contact tracing for HIV and tuberculosis in Malawi: an adaptive multi-arm multi-stage randomised trial (mPATCH-TB) |
| Amount | £112,515 (GBP) |
| Funding ID | MR/R019762/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2018 |
| End | 04/2020 |
| Description | Medical-Detection Dogs to Identify People with SARS-CoV-2 |
| Amount | £1,155,120 (GBP) |
| Organisation | Department of Health (DH) |
| Sector | Public |
| Country | United Kingdom |
| Start | 04/2020 |
| End | 02/2021 |
| Description | Menstrual health interventions, schooling and mental health symptoms among Ugandan students (MENISCUS): a school-based cluster-randomised trial |
| Amount | £3,265,055 (GBP) |
| Funding ID | MR/V005634/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 11/2020 |
| End | 10/2024 |
| Description | NIH - IMPlementation of evidence based facility and community interventions to reduce the treatment gap for depRESSion (IMPRESS) |
| Amount | $2,609,843 (USD) |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Sector | Academic/University |
| Country | United Kingdom |
| Start | 06/2020 |
| End | 04/2024 |
| Description | NIRG: Evaluation of interventions with rare events: methods for parallel cluster randomised trials and stepped-wedge cluster randomised trials |
| Amount | £414,285 (GBP) |
| Funding ID | MR/X029492/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2024 |
| End | 07/2027 |
| Description | Non-adherence to treatment: a methodological approach to compensating for its impact in chronic infections, using tuberculosis as a model disease. |
| Amount | £1,059,230 (GBP) |
| Funding ID | MR/R008345/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2018 |
| End | 08/2022 |
| Description | OPT SMC - Optimizing the impact of Seasonal Malaria Chemoprevention: improving delivery & building capacity for evaluation |
| Amount | € 530,296 (EUR) |
| Funding ID | CSA2018HS-2520-OPT-SMC |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 04/2020 |
| End | 04/2024 |
| Description | Operations research to measure the effectiveness of a peer-led mental health intervention on virological suppression and mental health among adolescents with HIV in Zimbabwe (ALHIV Adherence - Mental Health) |
| Amount | $40,202 (USD) |
| Organisation | AfricAid |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 02/2019 |
| End | 08/2020 |
| Description | Optimising seasonal malaria chemoprevention and seasonal vaccination in childhood to address the resurgent malaria burden in Africa |
| Amount | £916,159 (GBP) |
| Funding ID | 220658/Z/20/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2021 |
| End | 12/2026 |
| Description | PHSM Database - Ext 4 |
| Amount | £30,814 (GBP) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 04/2022 |
| End | 08/2022 |
| Description | Perceptions, knowledge and use (and mis-use) of over the counter analgesics in East and Southern Africa |
| Amount | £20,000 (GBP) |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 09/2019 |
| End | 03/2020 |
| Description | Pre-doctoral fellowship (Marietta Missinhoun) |
| Amount | £117,186 (GBP) |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 09/2022 |
| End | 08/2024 |
| Description | Randomised controlled trial of cipro vs standard of care in plague |
| Amount | £1,588,565 (GBP) |
| Funding ID | 216273/Z/19/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 11/2019 |
| End | 04/2023 |
| Description | Risk factors for genital inflammation among women at high risk of HIV in Uganda: a mixed-method, longitudinal analysis |
| Amount | £772,976 (GBP) |
| Funding ID | MR/R023182/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2019 |
| End | 12/2023 |
| Description | STIs in CHIEDZA |
| Amount | £1,009,735 (GBP) |
| Funding ID | MR/T040327/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 07/2020 |
| End | 07/2023 |
| Description | Significance of Hypertension in Early Adulthood Research (SHEAR) |
| Amount | £1,185,342 (GBP) |
| Funding ID | 227647/Z/23/Z |
| Organisation | Wellcome Trust |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 08/2024 |
| End | 08/2029 |
| Description | Spatial Intelligence System for precision larviciding |
| Amount | $796,731 (USD) |
| Organisation | IVCC |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 01/2018 |
| End | 09/2020 |
| Description | Systematic Review |
| Amount | $276,585 (USD) |
| Funding ID | INV-038132 |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 11/2021 |
| End | 10/2022 |
| Description | TB MATE |
| Amount | $73,273 (USD) |
| Organisation | Bill and Melinda Gates Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 05/2019 |
| End | 11/2021 |
| Description | TEBWA |
| Amount | € 749,658 (EUR) |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 06/2021 |
| End | 06/2024 |
| Description | TREATS-COVID - Understanding the Epidemiology of SARS-CoV-2 and the inter-relation of COVID-19 with TB and HIV in Zambia |
| Amount | € 82,310 (EUR) |
| Funding ID | RIA2020EF-3004 |
| Organisation | Sixth Framework Programme (FP6) |
| Department | European and Developing Countries Clinical Trials Partnership |
| Sector | Public |
| Country | Netherlands |
| Start | 06/2020 |
| End | 12/2021 |
| Description | TSA 1 Ext: To enhance the Public Health and Social Measures (PHSM) dataset through work with WHO |
| Amount | £76,586 (GBP) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 09/2021 |
| End | 04/2022 |
| Description | The Bioko Island Malaria Elimination Project (BIMEP) |
| Amount | £40,203 (GBP) |
| Organisation | Medical Care Development |
| Sector | Hospitals |
| Country | United States |
| Start | 01/2019 |
| End | 12/2019 |
| Description | The Zvandiri character strength and its constructs amoing adolescents living with HIV in Zimbabwe |
| Amount | £49,081 (GBP) |
| Organisation | Templeton World Charity Foundation |
| Sector | Charity/Non Profit |
| Country | Bahamas |
| Start | 09/2021 |
| End | 09/2024 |
| Description | The epidemiology of scrub typhus and rickettisial infections in a highly endemic rural setting in South India: Population-based Cohort Study. |
| Amount | £767,928 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2020 |
| End | 12/2022 |
| Description | To enhance the Public Health and Social Measures (PHSM) dataset through work with WHO |
| Amount | £126,291 (GBP) |
| Organisation | World Health Organization (WHO) |
| Sector | Public |
| Country | Global |
| Start | 09/2020 |
| End | 10/2021 |
| Description | UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE) |
| Amount | £1,202,460 (GBP) |
| Funding ID | MR/S019510/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2019 |
| End | 03/2023 |
| Description | Unlocking potential: developing innovative adolescent screening visits for health promotion, prevention and treatment in low-resource settings |
| Amount | £1,222,092 (GBP) |
| Funding ID | MR/T043156/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 02/2021 |
| End | 01/2025 |
| Description | Zvatinoda! (What we want!): Increasing demand and uptake of sexual and reproductive health services by young people in Zimbabwe |
| Amount | £151,520 (GBP) |
| Funding ID | MR/T003200/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2019 |
| End | 02/2022 |
| Title | Agreement and error of titration assays |
| Description | Methods for estimating the distribution of errors, at the level of a single replicate, from the distribution of within-pair agreement. Also a method for estimating sample required to estimate the degree of error. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | GCP and GCLP require assay performance to be quantified but this is largely lacking for titration assays. The methods in question allow performance to be quantified more easily. |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/35031278 |
| Title | CLIC Brazil |
| Description | Tracking COVID incidence and risk factors at municipality level in Brazil |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Tracking COVID incidence and risk factors at municipality level in Brazil |
| URL | https://cmmid.github.io/visualisations/lacpt |
| Title | CRT with few clusters |
| Description | CRT with few clusters |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | Paper provides guidance for analysing cluster randomised trials with few clusters |
| URL | https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-022-01699-2 |
| Title | Developing tools for population estimation methods (CG) |
| Description | Developing tools for population estimation methods |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | Tool available and used for estimating populations cheaply and rapidly. Used by MITU on other research projects. Also used by Lake Victoria Consortium. Method feeding into to other research around population estimation and currently in discussions with Gates Foundation for use in EPI and other vaccine work. |
| Title | Evaluation of statistical methods for handling autocorrelation in interrupted time series analyses |
| Description | Evaluation of statistical methods for handling autocorrelation in interrupted time series analyses |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | Paper provides guidance for analysing interrupted time series |
| URL | https://onlinelibrary.wiley.com/doi/full/10.1002/sim.9669 |
| Title | Method for estimating previous infection using mixture models |
| Description | Methodology used to estimate previous infection with SARS-Cov-2 in Kenya from various surveys conducted in 2020 and 2021 |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Methodology used to estimate previous infection with SARS-Cov-2 in Kenya from various surveys conducted in 2020 and 2021 |
| URL | https://www.nature.com/articles/s41467-021-26452-z |
| Title | ART and HPV |
| Description | Data from a systematic review on ART and HPV infection |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | Additional file 1 of Sputum bacterial load and bacterial composition correlate with lung function and are altered by long-term azithromycin treatment in children with HIV-associated chronic lung disease |
| Description | Additional file 1: Figure S1. A bar plot of the taxa and their relative abundance of the extraction and sequencing mock controls compared to manufacturer profiles. Figure S2. A scatterplot showing the correlation between samples repeated within a run (WR, n = 74) and between runs (BR, n=28). Figure S3. A scatterplot showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) 16S copies vs final number of reads (A1 and A2), Shannon alpha diversity index (B1 and B2) and age of participant in years (C1 and C2). Figure S4. Ordination plots of showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by their 16S copies. Figure S5. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by their number of reads. Figure S6. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the age of the participant. Figure S7. Rarefaction curves showing number of ASVs detected and 16S copies of samples. Figure S8. Rarefaction curves showing number of ASVs detected and number of reads of samples. Figure S9. Bar plot showing the profiles of biological samples with <100 16S copies (n=2) in comparison to Primestores profiles (n=43). Figure S10. Bar plot showing the profiles of biological samples with >100 to <1000 16S copies (n=10) in comparison to Primestores profiles (n=43). Figure S11. Ordination plots showing the profiles of a subset of biological samples with low 16S copies and the negative controls. Figure S12. Ordination plots showing the profiles of a subset of biological samples with low reads and the negative controls. Figure S13. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the run in which the sample was processed. Figure S14. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the country of sampling. Figure S15. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by visit. Figure S16. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the age at sampling. Figure S17. Output from decontamination analysis using the DECONTAM R package. Figure S18. Boxplot of Shannon alpha diversity index between trial arms at each visit (A) and between study visits in AZM (B) and Placebo (C) arms. Figure S19. Violin boxplot comparing two beta diversity metrics between samples collected from participants in the AZM arms at baseline and 48 weeks, 48 and 72 weeks and baseline and 72 weeks. Figure S20. Violin boxplot comparing two beta diversity metrics between samples collected from participants in the Placebo arms at baseline and 48 weeks, 48 and 72 weeks and baseline and 72 weeks. Figure S21. Principal Coordinates Analysis of Atchison (A) and Bray-Curtis (B) [on unrarefied ASV counts] distance matrixes between trial arms at each visit. Figure S22. Barplot of the relative abundances of the top 10 most prevalent phyla in all samples. Figure S23. Barplot of the relative abundances of the top 12 most prevalent genera in all samples. Figure S24. Heatmap displaying the q values of the genera detected as differentially abundant between AZM and placebo arms at 48 weeks by 10 statistical methods. Figure S25. Heatmap displaying the q values of the genera detected as differentially abundant within the AZM arm between baseline and 48-week samples by 10 methods. Figure S26. Heatmap displaying the q values of the genera detected as differentially abundant within the AZM arm between 48- and 72-week samples by 10 methods. Table S1. The taxonomy of the ASVs in the extraction and sequencing control. Table S2. List of 70 ASVs detected by the DECONTAM R package as potential contaminants based on comparison between biological samples and negative controls. Table S3. The association between bacterial load (16S rRNA copies) and selected variables using linear mixed effects modelling. Table S4. The association between Shannon diversity indices and selected variables using linear mixed effects modelling. Table S5. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 48 weeks using 10 methods. Table S6. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 72 weeks using DESeq2. Table S7. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 72 weeks using Ancom-II. Table S8. Results of differential abundance testing of bacterial taxa from samples from the AZM arm at baseline and 48 72 weeks using 10 methods. Table S9. Results of differential abundance testing of bacterial taxa from samples from the AZM arm at 48 and 72 weeks using 10 methods. Table S10. Results of differential abundance testing of bacterial taxa from Placebo samples from 48 and 72 weeks using DESeq2. Table S11. Results of differential abundance testing of bacterial taxa from Placebo samples from baseline and 72 weeks using DESeq2. Table S12. Contributions of top genera to overall dissimilarity between AZM and Placebo arms at 48 weeks and, within the AZM arm, between Baseline and 48-week samples- SIMPER analysis. Table S13. Univariate linear regression analysis of within-participant Aitchison distance (outcome) and within-participant change in lung function metrics (FVCz and FEV1z) between visits. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Sputum_bacterial_load_and_... |
| Title | Additional file 1 of Sputum bacterial load and bacterial composition correlate with lung function and are altered by long-term azithromycin treatment in children with HIV-associated chronic lung disease |
| Description | Additional file 1: Figure S1. A bar plot of the taxa and their relative abundance of the extraction and sequencing mock controls compared to manufacturer profiles. Figure S2. A scatterplot showing the correlation between samples repeated within a run (WR, n = 74) and between runs (BR, n=28). Figure S3. A scatterplot showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) 16S copies vs final number of reads (A1 and A2), Shannon alpha diversity index (B1 and B2) and age of participant in years (C1 and C2). Figure S4. Ordination plots of showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by their 16S copies. Figure S5. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by their number of reads. Figure S6. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the age of the participant. Figure S7. Rarefaction curves showing number of ASVs detected and 16S copies of samples. Figure S8. Rarefaction curves showing number of ASVs detected and number of reads of samples. Figure S9. Bar plot showing the profiles of biological samples with <100 16S copies (n=2) in comparison to Primestores profiles (n=43). Figure S10. Bar plot showing the profiles of biological samples with >100 to <1000 16S copies (n=10) in comparison to Primestores profiles (n=43). Figure S11. Ordination plots showing the profiles of a subset of biological samples with low 16S copies and the negative controls. Figure S12. Ordination plots showing the profiles of a subset of biological samples with low reads and the negative controls. Figure S13. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the run in which the sample was processed. Figure S14. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the country of sampling. Figure S15. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by visit. Figure S16. Ordination plots showing the spread of biological samples (n=960) and the negative controls (primestore, n=43) coloured by the age at sampling. Figure S17. Output from decontamination analysis using the DECONTAM R package. Figure S18. Boxplot of Shannon alpha diversity index between trial arms at each visit (A) and between study visits in AZM (B) and Placebo (C) arms. Figure S19. Violin boxplot comparing two beta diversity metrics between samples collected from participants in the AZM arms at baseline and 48 weeks, 48 and 72 weeks and baseline and 72 weeks. Figure S20. Violin boxplot comparing two beta diversity metrics between samples collected from participants in the Placebo arms at baseline and 48 weeks, 48 and 72 weeks and baseline and 72 weeks. Figure S21. Principal Coordinates Analysis of Atchison (A) and Bray-Curtis (B) [on unrarefied ASV counts] distance matrixes between trial arms at each visit. Figure S22. Barplot of the relative abundances of the top 10 most prevalent phyla in all samples. Figure S23. Barplot of the relative abundances of the top 12 most prevalent genera in all samples. Figure S24. Heatmap displaying the q values of the genera detected as differentially abundant between AZM and placebo arms at 48 weeks by 10 statistical methods. Figure S25. Heatmap displaying the q values of the genera detected as differentially abundant within the AZM arm between baseline and 48-week samples by 10 methods. Figure S26. Heatmap displaying the q values of the genera detected as differentially abundant within the AZM arm between 48- and 72-week samples by 10 methods. Table S1. The taxonomy of the ASVs in the extraction and sequencing control. Table S2. List of 70 ASVs detected by the DECONTAM R package as potential contaminants based on comparison between biological samples and negative controls. Table S3. The association between bacterial load (16S rRNA copies) and selected variables using linear mixed effects modelling. Table S4. The association between Shannon diversity indices and selected variables using linear mixed effects modelling. Table S5. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 48 weeks using 10 methods. Table S6. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 72 weeks using DESeq2. Table S7. Results of differential abundance testing of bacterial taxa from AZM and Placebo samples from 72 weeks using Ancom-II. Table S8. Results of differential abundance testing of bacterial taxa from samples from the AZM arm at baseline and 48 72 weeks using 10 methods. Table S9. Results of differential abundance testing of bacterial taxa from samples from the AZM arm at 48 and 72 weeks using 10 methods. Table S10. Results of differential abundance testing of bacterial taxa from Placebo samples from 48 and 72 weeks using DESeq2. Table S11. Results of differential abundance testing of bacterial taxa from Placebo samples from baseline and 72 weeks using DESeq2. Table S12. Contributions of top genera to overall dissimilarity between AZM and Placebo arms at 48 weeks and, within the AZM arm, between Baseline and 48-week samples- SIMPER analysis. Table S13. Univariate linear regression analysis of within-participant Aitchison distance (outcome) and within-participant change in lung function metrics (FVCz and FEV1z) between visits. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Sputum_bacterial_load_and_... |
| Title | Additional file 2 of Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method |
| Description | Additional file 2. Code to replicate illustrative example. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Cluster_randomised_trials_... |
| Title | Additional file 2 of Cluster randomised trials with a binary outcome and a small number of clusters: comparison of individual and cluster level analysis method |
| Description | Additional file 2. Code to replicate illustrative example. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Cluster_randomised_trials_... |
| Title | Additional file 2: of Reported oral and anal sex among adolescents and adults reporting heterosexual sex in sub-Saharan Africa: a systematic review |
| Description | Table S1. Selected data from quantitative studies reporting on heterosexual oral and anal sex in sub-Saharan Africa by year of publication. Table S2. Reported condom use during penetrative heterosexual sex (oral, anal and vaginal). Table S3. Risk of bias assessment for quantitative studies. Table S4. Risk of bias assessment of qualitative studies. (XLSX 41 kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/Additional_file_2_of_Reported_oral_and_anal_sex_among_a... |
| Title | Additional file 2: of Reported oral and anal sex among adolescents and adults reporting heterosexual sex in sub-Saharan Africa: a systematic review |
| Description | Table S1. Selected data from quantitative studies reporting on heterosexual oral and anal sex in sub-Saharan Africa by year of publication. Table S2. Reported condom use during penetrative heterosexual sex (oral, anal and vaginal). Table S3. Risk of bias assessment for quantitative studies. Table S4. Risk of bias assessment of qualitative studies. (XLSX 41 kb) |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| URL | https://springernature.figshare.com/articles/Additional_file_2_of_Reported_oral_and_anal_sex_among_a... |
| Title | Breathe |
| Description | BREATHE trial dataset |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | Combined HIV Adolescent Prevention Study (CHAPS): qualitative survey data |
| Description | This dataset contains survey responses collected from 1,330 young people from South Africa, Uganda and Zimbabwe who took part in the CHAPS social science quantitative survey. The primary purpose of the survey was to investigate demographics and socio-behavioural risk factors related to HIV pre-exposure prophylaxis (PrEP) preferences amongst young people. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | https://datacompass.lshtm.ac.uk/id/eprint/2892 |
| Title | Community based interventions to improve HIV outcomes in youth: a cluster randomised trial in Zimbabwe (CHIEDZA) |
| Description | Young people fare disproportionately poorly across the HIV care continuum compared to other age-groups; the prevalence of undiagnosed HIV is substantially higher, and coverage of and adherence to antiretroviral therapy is lower, resulting overall in worse virological outcomes. The aim of the CHIEDZA trial is to determine the impact of an integrated community-based package of HIV services incorporating HIV testing, linkage to care and ongoing adherence support, combined with sexual and reproductive health services and general health counselling for 16 to 24 year olds on population level HIV viral load in a high HIV prevalence setting. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | https://datacompass.lshtm.ac.uk/id/eprint/2718 |
| Title | Data for Thinking Healthy Programme India trial (THPP-India) |
| Description | An anonymised dataset of 280 women (one row per woman) who gave informed consent to participate in an individually-randomised, parallel, superiority, controlled trial in Goa, India in 2014-2016. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/793 |
| Title | Data for Thinking Healthy Programme Pakistan trial (THPP-Pakistan) |
| Description | An anonymised dataset of 570 women (one row per woman) who gave informed consent to participate in a cluster randomised, parallel, superiority, controlled trial in Rawalpindi, Pakistan in 2014-2017. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation and clusters, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2018 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/794 |
| Title | Ebola Contact Tracing Study data |
| Description | The collection contains four datasets captured in the Ebola Contact Tracing Study: [1] 'summary_data_cases' contains details of the 41 confirmed Ebola cases included in the study; [2] 'app_data_contacts' contains details of the 646 Ebola contacts registered on the Ebola Contact Tracing App (ECT) smartphone app. These originate from 18 Ebola cases (16 were laboratory confirmed and 2 were "secret burials" that were not confirmed); [3] 'paper_data_contacts' describes 408 Ebola contacts who were identified from 25 Ebola cases for monitoring using the standard paper-based system for contact tracing; and [4] 'main_analysis_dataset' contains information on 804 Ebola contacts and their contact tracing monitoring status collected using both the ECT app and paper-based system. THESE DATASETS ARE EMBARGOED UNTIL 1st JUNE 2019. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/id/eprint/1069 |
| Title | Friendship Bench |
| Description | Friendship Bench dataset |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | none yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | HetMal |
| Description | Collation of malaria CRT cluster data. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2022 |
| Provided To Others? | No |
| Impact | None yet. |
| Title | LaVIISWA and USAMO |
| Description | Data from the LaVIISWA CRT and Urban Survey |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | POPVAC |
| Description | POPVAC trials datasets. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | None yet. |
| URL | http://datacompass.lshtm.ac.uk |
| Title | PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Counselling for Alcohol Problems (CAP) RCT |
| Description | Datasets for the two PREMIUM trials |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/514/ |
| Title | PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Healthy Activity Program (HAP) RCT |
| Description | Datasets for the two PREMIUM trials |
| Type Of Material | Database/Collection of data |
| Year Produced | 2017 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk/513/ |
| Title | SONA |
| Description | Data from the SONA asthma case-control study |
| Type Of Material | Database/Collection of data |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | STICH |
| Description | STICH trial dataset |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | TB FastTrack |
| Description | Data from the TB FastTrack CRT |
| Type Of Material | Database/Collection of data |
| Year Produced | 2019 |
| Provided To Others? | Yes |
| Impact | None yet |
| URL | http://datacompass.lshtm.ac.uk |
| Title | WHO NPI Database |
| Description | global database on public health and social measures (PHSM) implemented by countries to reduce the spread of COVID-19. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| URL | https://github.com/lshtm-gis/WHO-PHSM |
| Description | AKU pediatric HIV |
| Organisation | Aga Khan University |
| Country | Pakistan |
| Sector | Academic/University |
| PI Contribution | Statistician |
| Collaborator Contribution | Analysis and writing report |
| Impact | None |
| Start Year | 2022 |
| Description | AMARI-II |
| Organisation | University of Zimbabwe |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | Co-I |
| Collaborator Contribution | Strategic advice |
| Impact | None yet |
| Start Year | 2023 |
| Description | ASCENT |
| Organisation | KNCV Tuberculosis Foundation |
| Country | Netherlands |
| Sector | Charity/Non Profit |
| PI Contribution | Lead on Ethiopian research; study design |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2019 |
| Description | Africa CDC seroprevalence surveys |
| Organisation | Africa Centres For Disease Control And Prevention |
| Country | Ethiopia |
| Sector | Charity/Non Profit |
| PI Contribution | Statistician |
| Collaborator Contribution | Design, implementation, data |
| Impact | Epidemiology, statistics |
| Start Year | 2021 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | Universidade de São Paulo |
| Country | Brazil |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CADDE (UK-Brazil Joint Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology) |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design and analysis, training |
| Collaborator Contribution | Genetics, public health, virology |
| Impact | Next Generation Sequencing workshop held in Sao Paulo, December 2019. Multidisciplinary: Genetics, public health, virology |
| Start Year | 2018 |
| Description | CEASE |
| Organisation | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design and analysis |
| Collaborator Contribution | entomology |
| Impact | entomology, modelling, social science |
| Start Year | 2021 |
| Description | CHANGE |
| Organisation | HealthRight International |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | HealthRight International |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | National University of Kyiv Mohyla Academy |
| Country | Ukraine |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: alcohol use disorders, humanitarian health, clinical trials |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | National University of Kyiv Mohyla Academy |
| Country | Ukraine |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHANGE |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | Leiden University Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | MRC/UVRI Uganda Research Unit on AIDS |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CHI-S (E.Webb) |
| Organisation | Ministry of Health, Uganda |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Study design, trial statistician |
| Collaborator Contribution | Study design; coordination; field activities; lab studies |
| Impact | None yet, papers in preparation. Multidisciplinary: epidemiology, public health, statistics, clinical trials |
| Start Year | 2020 |
| Description | CONTAGIO |
| Organisation | Heidelberg University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | LSHTM PI, and leader for tasks in two work packages |
| Collaborator Contribution | Making tools for epidemic preparedness. |
| Impact | No current outputs |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Armauer Hansen Research Institute |
| Country | Ethiopia |
| Sector | Charity/Non Profit |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Kilimanjaro Christian Medical University College |
| Country | Tanzania, United Republic of |
| Sector | Academic/University |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Nigeria Institute of Medical Research |
| Country | Nigeria |
| Sector | Private |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Swiss Tropical & Public Health Institute |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | CONVINCE (Country operationalised novel vector interventions for malaria control) |
| Organisation | Tulane University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Senior epidemiologist, study design |
| Collaborator Contribution | Supporting country teams with epi and ento evaluations |
| Impact | None yet |
| Start Year | 2024 |
| Description | COVADIS |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Unit, The Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | Statistician |
| Collaborator Contribution | Data analysis and interpretation |
| Impact | Epidemiology, statistics |
| Start Year | 2021 |
| Description | CRT with time to event outcomes |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2019 |
| Description | Clinical trial - MONART |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | Clinical trial - MONART |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | Clinical trial - MONART |
| Organisation | University of Sussex |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise, information technology |
| Impact | None yet |
| Start Year | 2020 |
| Description | Cluster level GLM |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-PI for project |
| Collaborator Contribution | Expertise in estimands |
| Impact | Epidemiology |
| Start Year | 2022 |
| Description | Co-Host |
| Organisation | MRC/UVRI Uganda Research Unit on AIDS |
| Country | Uganda |
| Sector | Public |
| PI Contribution | Co-PI for project |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epidemiology, statistics, child health, vaccinology |
| Start Year | 2021 |
| Description | Co-Host |
| Organisation | Medical Research Council (MRC) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Co-PI for project |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epidemiology, statistics, child health, vaccinology |
| Start Year | 2021 |
| Description | Covid Seroprevalence |
| Organisation | Government of The Gambia |
| Department | Ministry of Health Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | Study design/Analysis support |
| Collaborator Contribution | Design, implementation, data |
| Impact | Public health ,epidemiology, statistics |
| Start Year | 2021 |
| Description | DREAMS Year 6 evaluation |
| Organisation | African Population and Health Research Center |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Joint PI at LSHTM |
| Collaborator Contribution | Design, implementation, analysis, writing |
| Impact | Epidemiology, statistics, social science |
| Start Year | 2022 |
| Description | DREAMS Year 6 evaluation |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Department | KEMRI CGMRC Programme |
| Country | Kenya |
| Sector | Charity/Non Profit |
| PI Contribution | Joint PI at LSHTM |
| Collaborator Contribution | Design, implementation, analysis, writing |
| Impact | Epidemiology, statistics, social science |
| Start Year | 2022 |
| Description | EDCTP GIFT |
| Organisation | Burnet Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Desmond Tutu HIV Foundation |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Organization for Public Health Interventions and Development |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Pasteur Institute of Madagascar |
| Country | Madagascar |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Pasteur Institute, Morocco |
| Country | Morocco |
| Sector | Public |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | Sophia University Japan |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | University Medical Center Utrecht (UMC) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP GIFT |
| Organisation | University of Cape Town |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | To develop guidelines for the integration of the GIFT device into current STI/BV management strategies in Africa |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EDCTP TEBWA |
| Organisation | National Hospital of Pneumo-Phtisiology |
| Country | Benin |
| Sector | Hospitals |
| PI Contribution | Teaching, mentoring |
| Collaborator Contribution | Design, implementation |
| Impact | None yet |
| Start Year | 2021 |
| Description | EMaBS at 21 |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Principal Investigator |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | No outputs currently |
| Start Year | 2024 |
| Description | ENTRANT |
| Organisation | Haramaya University |
| Country | Ethiopia |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | National Health Laboratory |
| Country | Botswana |
| Sector | Hospitals |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | National Institute for Medical Research, Tanzania |
| Department | Mwanza Intervention Trials Unit (MITU) |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | University of Nairobi |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | ENTRANT |
| Organisation | Zambart |
| Country | Zambia |
| Sector | Public |
| PI Contribution | Project lead/coordinator, teaching, mentoring |
| Collaborator Contribution | Mentoring, applicant selection |
| Impact | Project just started, none yet. |
| Start Year | 2021 |
| Description | EVOLVE |
| Organisation | Francis Crick Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Senior statistician, co-I |
| Collaborator Contribution | Design and analysis |
| Impact | Epidemiology, immunology, vaccines, laboratory science |
| Start Year | 2021 |
| Description | Estimands in Stepped Wedge Trials |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | No impact yet |
| Start Year | 2019 |
| Description | Expanded vector control toolbox to fight malaria |
| Organisation | Centre for Research in Infectious Diseases (CRID) |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design, statistical analysis |
| Collaborator Contribution | Leading the consortium, managing fieldwork, negotiating with funder |
| Impact | None yet |
| Start Year | 2024 |
| Description | FIEBRE |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Statistician |
| Collaborator Contribution | Analysis |
| Impact | None yet |
| Start Year | 2023 |
| Description | FIEBRE |
| Organisation | Mahosot Hospital |
| Country | Lao People's Democratic Republic |
| Sector | Hospitals |
| PI Contribution | Statistician |
| Collaborator Contribution | Analysis |
| Impact | None yet |
| Start Year | 2023 |
| Description | FIEBRE |
| Organisation | University of Oxford |
| Department | Oxford Hub |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistician |
| Collaborator Contribution | Analysis |
| Impact | None yet |
| Start Year | 2023 |
| Description | FIEBRE |
| Organisation | Wellcome Trust |
| Department | Wellcome Trust Clinical Research Facility |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Statistician |
| Collaborator Contribution | Analysis |
| Impact | None yet |
| Start Year | 2023 |
| Description | Fractional dose pneumococcal vaccine trial |
| Organisation | Wellcome Trust |
| Department | KEMRI-Wellcome Trust Research Programme |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | Statistician for RCT |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epidemiology, Vaccinology |
| Start Year | 2019 |
| Description | Heterogeneity in trials |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | PI and primary analyst |
| Collaborator Contribution | Mathematical modelling |
| Impact | Epidemiology, statistics, mathematical modelling |
| Start Year | 2021 |
| Description | Household NCD screening |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | PI |
| Collaborator Contribution | Design, implementation, analysis |
| Impact | Epidemiology, social science |
| Start Year | 2022 |
| Description | IMPACT-BP |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | Harvard University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | University of Bordeaux |
| Country | France |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPACT-BP |
| Organisation | University of East Anglia |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | study design; statistical advice; analysis |
| Collaborator Contribution | design, implementation, specialist clinical expertise |
| Impact | None yet |
| Start Year | 2018 |
| Description | IMPALA |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Statistician |
| Collaborator Contribution | Study design and protocol development |
| Impact | Statistics, health economics, TB clinical therapy |
| Start Year | 2021 |
| Description | IMPRESS |
| Organisation | Sangath |
| Country | India |
| Sector | Charity/Non Profit |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2020 |
| Description | IMPRESS |
| Organisation | University of Malawi |
| Department | College of Medicine |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Statistician for CRT |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Economics, social science, child health, epidemiology |
| Start Year | 2021 |
| Description | INPUTT |
| Organisation | Fred Hutchinson Cancer Research Center (FHCRC) |
| Department | Statistical Center for HIV/AIDS Research and Prevention (SCHARP) |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | INPUTT |
| Organisation | University of Oxford |
| Department | Big Data Institute |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | INPUTT |
| Organisation | Zambart |
| Country | Zambia |
| Sector | Public |
| PI Contribution | Coordination, statistical analysis, publication |
| Collaborator Contribution | Analysis, publication |
| Impact | None yet |
| Start Year | 2020 |
| Description | INTREPID-III |
| Organisation | King's College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-I |
| Collaborator Contribution | Strategic advice |
| Impact | None yet |
| Start Year | 2023 |
| Description | ITENs |
| Organisation | Ifakara Health Institute |
| Country | Tanzania, United Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | PI on grant |
| Collaborator Contribution | entomology |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | IVCC |
| Organisation | Ifakara Health Institute |
| Country | Tanzania, United Republic of |
| Sector | Charity/Non Profit |
| PI Contribution | statistician |
| Collaborator Contribution | Design and analysis |
| Impact | entomology |
| Start Year | 2022 |
| Description | Kintampo RTS,S safety study |
| Organisation | Kintampo Health Research Centre |
| Country | Ghana |
| Sector | Hospitals |
| PI Contribution | Statistical advisory role, help with analysis plans |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | None yet |
| Start Year | 2020 |
| Description | LINEA |
| Organisation | National Institute for Medical Research, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Co-I |
| Collaborator Contribution | Strategic advice |
| Impact | None yet |
| Start Year | 2023 |
| Description | Longitudinal CRTs |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | Online tool. Paper submitted |
| Start Year | 2019 |
| Description | Lurkana HIV paediatric outbreak |
| Organisation | Aga Khan University |
| Country | Pakistan |
| Sector | Academic/University |
| PI Contribution | study statistician |
| Collaborator Contribution | fieldwork, study coordination, knowledge of setting, clinical input, political engagement |
| Impact | two publications, main results paper in progress. Multidisciplinary: epidemiology, molecular epidemiology |
| Start Year | 2019 |
| Description | MASSIV |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Unit, The Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | Statistician |
| Collaborator Contribution | Data analysis and interpretation |
| Impact | Epidemiology, Entomology, statistics |
| Start Year | 2021 |
| Description | MBIRA observational study |
| Organisation | Centro de Investigação em Saúde de Manhiça |
| Country | Mozambique |
| Sector | Charity/Non Profit |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Hiwot Fana Hospital |
| Country | Ethiopia |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Kamuzu Central Hospital |
| Country | Malawi |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Kilimanjaro Christian Medical Centre (KCMS) |
| Country | Tanzania, United Republic of |
| Sector | Hospitals |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Njala University, Sierra Leone |
| Country | Sierra Leone |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Accra |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Jos |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Stellenbosch |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | University of Zimbabwe |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Wellcome Trust |
| Department | KEMRI-Wellcome Trust Research Programme |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MBIRA observational study |
| Organisation | Wellcome Trust |
| Department | KEMRI-Wellcome Trust Research Programme, Uganda |
| Country | Uganda |
| Sector | Charity/Non Profit |
| PI Contribution | design, analysis |
| Collaborator Contribution | clinical, field, project management |
| Impact | None yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MENISCUS |
| Organisation | WoMena, Uganda |
| Country | Uganda |
| Sector | Charity/Non Profit |
| PI Contribution | Overall lead; study design; analysis |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | No impact yet |
| Start Year | 2020 |
| Description | MERS-CoV in Jordan |
| Organisation | Royal Veterinary College (RVC) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Fieldwork in, and knowledge of, Jordan and knowledge of camels and camel infections |
| Impact | None yet, two papers in preparation. Discipline: vet epidemiology |
| Start Year | 2016 |
| Description | MOBILE MEN |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | Trial design and analysis, LSHTM PI, WP lead for knowledge exchange |
| Collaborator Contribution | Design, implementation, analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | MOBILE MEN |
| Organisation | King's College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Trial design and analysis, LSHTM PI, WP lead for knowledge exchange |
| Collaborator Contribution | Design, implementation, analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | MOBILE MEN |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Trial design and analysis, LSHTM PI, WP lead for knowledge exchange |
| Collaborator Contribution | Design, implementation, analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | MOBILE MEN |
| Organisation | University College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Trial design and analysis, LSHTM PI, WP lead for knowledge exchange |
| Collaborator Contribution | Design, implementation, analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | MRC QMUL COMBI |
| Organisation | Queen Mary University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical input |
| Collaborator Contribution | Design, implementation, analysis, interpretation |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Department | Institute of Research in Health Sciences |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | University Cheikh Anta Diop de Dakar |
| Country | Senegal |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | Matt's Wellcome Fellowship |
| Organisation | University of Bamako |
| Department | Malaria Research and Training Centre (MRTC) Bamako |
| Country | Mali |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Specialist expertise |
| Impact | None yet |
| Start Year | 2021 |
| Description | NCD Risk Factor Collaboration |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Data sharing, intellectual contribution to upcoming manuscript |
| Collaborator Contribution | Principal Investigator |
| Impact | None yet |
| Start Year | 2024 |
| Description | NPI database phase I |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | We developed a taxonomy with WHO to allow the data to be coded and we developed a taxonomy with WHO to allow the data to be coded. |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| Start Year | 2020 |
| Description | NPI database phase II |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | • Firstly we developed a taxonomy with WHO to allow the data to be coded. This taxonomy is now widely used by several other groups who collect their own datasets. So Both within WHO and external groups there are several datasets related to public health and social measures (PHSM) that are based on our taxonomy. • Secondly we developed a set of core variables required and ways of thinking about how we collect this type of policy information. Again these ideas have been adopted and influenced several of the largest trackers which are used widely. • The dataset was the first to bring together data from multiple sources and in doing this we produced mapping between the different groups datasets. We also introduced the idea that this was more sustainable and comprehensive way to collect data. It has led to the other groups establishing a network of PHSM trackers and many groups are now incorporating the same ideas into their datasets • The dataset itself is used by WHO, and is available through their website. They are currently in the process of incorporating the data into their covid19 dashboard. • The data is being used by modellers to look at the impact of policies on the pandemic, we are also using the data to look at what impact completeness of the trackers may have, as we have the ability to compare 5 different trackers. • Finally the dataset is being used to look at ML applications both in terms of automated bring different datasets together, coding existing data and to produce severity indicators |
| Start Year | 2020 |
| Description | Net Transition Initiative |
| Organisation | Institut Pierre Richet (IPR) |
| Country | Cote d'Ivoire |
| Sector | Academic/University |
| PI Contribution | Joint PI , design, analysis, entomologists |
| Collaborator Contribution | Implementation, entomologists, epidemiologists |
| Impact | Epidemiology, Entomology |
| Start Year | 2022 |
| Description | Net Transition Initiative |
| Organisation | University of Ottawa |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Joint PI , design, analysis, entomologists |
| Collaborator Contribution | Implementation, entomologists, epidemiologists |
| Impact | Epidemiology, Entomology |
| Start Year | 2022 |
| Description | Oleylphosphocholine for the treatment of Old World Cutaneous Leishmaniasis(TT4CL) |
| Organisation | St George's University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Clinical field and lab studies. |
| Impact | None yet. Multidisciplinary: epidemiology, clinical trials, immunology |
| Start Year | 2019 |
| Description | PDC/Baby Ubuntu CRT |
| Organisation | Partners In Health |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Senior statistician, co-I |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | PDC/Baby Ubuntu CRT |
| Organisation | Rwanda Biomedical Center |
| Country | Rwanda |
| Sector | Hospitals |
| PI Contribution | Senior statistician, co-I |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | No outputs currently |
| Start Year | 2023 |
| Description | Peek |
| Organisation | Peekvsion |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Technology, programme delivery |
| Impact | Multidisciplinary: statistics, clinical trials |
| Start Year | 2020 |
| Description | Plague in Madagascar |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | trial statistician |
| Collaborator Contribution | design and coordination of the study |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | Population estimation methods for PNG |
| Organisation | Medicines for Malaria Venture (MMV) |
| Country | Switzerland |
| Sector | Charity/Non Profit |
| PI Contribution | Design and analsysis of population estimation |
| Collaborator Contribution | Fieldwork, study coordination, provision of imagery |
| Impact | none yet. Multidisciplinary: Epidemiology, GIS, data science |
| Start Year | 2019 |
| Description | Population mortality estimation for drought-affected regions of the Horn of Africa |
| Organisation | SIMAD University |
| Country | Somalia |
| Sector | Academic/University |
| PI Contribution | GIS/Data Science/Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | Epidemiology, statistics, Data science |
| Start Year | 2022 |
| Description | Prospective estimation of population mortality in drought-affected Somalia |
| Organisation | SIMAD University |
| Country | Somalia |
| Sector | Academic/University |
| PI Contribution | GIS/Data Science/Statistical support |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | Epidemiology, statistics, Data science |
| Start Year | 2022 |
| Description | R21 |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | analysis |
| Collaborator Contribution | vaccine development |
| Impact | vaccine development |
| Start Year | 2022 |
| Description | R21 Phase II statistical support |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical support/advice to analysis of R21 vaccine phase II trial |
| Collaborator Contribution | Design, implementation and analysis (including most statistical aspects) |
| Impact | Paper published (Datoo et al, Lancet, 2021) Epidemiology, Vaccinology, Statistics, Clinical Trials |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Centre for Research in Infectious Diseases (CRID) |
| Country | Cameroon |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Cote D'Ivoire's National Institute of Public Health |
| Country | Cote d'Ivoire |
| Sector | Public |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Mahidol University |
| Country | Thailand |
| Sector | Academic/University |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | Malaria Consortium |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RAFT |
| Organisation | National Institute for Medical Research, Tanzania |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Epidemiology lead, study design |
| Collaborator Contribution | Lab studies, entomological expertise, modellers |
| Impact | None yet |
| Start Year | 2020 |
| Description | RH5 |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Senior statistician, co-I |
| Collaborator Contribution | Design and analysis of 2 phase 2 trials |
| Impact | None yet |
| Start Year | 2023 |
| Description | Recruitment in stepped wedge trials |
| Organisation | François Rabelais University or University of Tours |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Statistical support |
| Collaborator Contribution | study design and analysis |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | Risk of bias in cluster randomized trials |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | PhD student supervision and statistical support |
| Collaborator Contribution | Design and analysis, and supervision |
| Impact | None yet. Multidisciplinary: statistics, clinical trials |
| Start Year | 2019 |
| Description | SSACAB-II |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Department | KEMRI CGMRC Programme |
| Country | Kenya |
| Sector | Charity/Non Profit |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | SSACAB-II |
| Organisation | Moi University |
| Country | Kenya |
| Sector | Academic/University |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | SSACAB-II |
| Organisation | University of Abomey-Calavi |
| Country | Benin |
| Sector | Academic/University |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | SSACAB-II |
| Organisation | University of KwaZulu-Natal |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | SSACAB-II |
| Organisation | University of Pretoria |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | SSACAB-II |
| Organisation | University of the Witwatersrand |
| Country | South Africa |
| Sector | Academic/University |
| PI Contribution | LSHTM PI - northern partner, providing support for the 6 lead institution |
| Collaborator Contribution | Leading the research themes |
| Impact | None yet |
| Start Year | 2024 |
| Description | STICH |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | PI on grant |
| Collaborator Contribution | Co-PI and implementation |
| Impact | None yet |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Ibadan |
| Country | Nigeria |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Makeni |
| Country | Sierra Leone |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | SUCCEED |
| Organisation | University of Malawi |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Design, implementation, analysis, interpret |
| Impact | Multidisciplinary: Disability, epidemiology, mental health, clinical trials |
| Start Year | 2020 |
| Description | SW-CRT small number of clusters |
| Organisation | Queen Mary University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Statistical expertise |
| Collaborator Contribution | Leading the research |
| Impact | None yet |
| Start Year | 2024 |
| Description | Scrub typhus India |
| Organisation | Christian Medical College, Vellore |
| Country | India |
| Sector | Academic/University |
| PI Contribution | Design of study and analysis of results |
| Collaborator Contribution | Epidemiology, ecology, one health |
| Impact | https://onlinelibrary.wiley.com/doi/abs/10.1111/tmi.13322 Multidisciplinary: epidemiology, clinical science, entomology, statistics, diagnostic assays |
| Start Year | 2018 |
| Description | Social and behavioral norms related to social protection |
| Organisation | Ipsos MORI |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Statistical support for sample design and analysis |
| Collaborator Contribution | Ipsos coordinating data collection ; UNICEF funding |
| Impact | Surveys from 7 countries measuring social norms, publications. Multi-disciplinary: epidemiology, public health, qualitative/anthropology |
| Start Year | 2020 |
| Description | Social and behavioral norms related to social protection |
| Organisation | UNICEF |
| Country | United States |
| Sector | Public |
| PI Contribution | Statistical support for sample design and analysis |
| Collaborator Contribution | Ipsos coordinating data collection ; UNICEF funding |
| Impact | Surveys from 7 countries measuring social norms, publications. Multi-disciplinary: epidemiology, public health, qualitative/anthropology |
| Start Year | 2020 |
| Description | Subclinical TB |
| Organisation | Africa Health Research Institute |
| Country | South Africa |
| Sector | Charity/Non Profit |
| PI Contribution | Statistician |
| Collaborator Contribution | Study design and sample size estimation |
| Impact | Epidemiology, statistics, health economics, immunology, mathematical modelling |
| Start Year | 2022 |
| Description | Subclinical TB |
| Organisation | Medical Research Council (MRC) |
| Department | MRC Unit, The Gambia |
| Country | Gambia |
| Sector | Public |
| PI Contribution | Statistician |
| Collaborator Contribution | Study design and sample size estimation |
| Impact | Epidemiology, statistics, health economics, immunology, mathematical modelling |
| Start Year | 2022 |
| Description | Support to Issaka Zongo EDCTP fellowship |
| Organisation | National Center for Scientific and Technological Research (CNRST) |
| Department | Institute of Research in Health Sciences |
| Country | Burkina Faso |
| Sector | Public |
| PI Contribution | Statistical support/mentoring of PI |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epidemiology, Clinical Trials |
| Start Year | 2021 |
| Description | TB GAPS |
| Organisation | Baylor College of Medicine |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Statistician for quasi-experimental design; Co-I |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epi; health economics |
| Start Year | 2021 |
| Description | TB GAPS |
| Organisation | Texas Children's Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Statistician for quasi-experimental design; Co-I |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | Epi; health economics |
| Start Year | 2021 |
| Description | Technical assistance to support implementation of NAP ECM, Bangladesh |
| Organisation | International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) |
| Country | Bangladesh |
| Sector | Public |
| PI Contribution | Interim PI, M&E lead/statistician |
| Collaborator Contribution | Study design and implementation |
| Impact | Epidemiology |
| Start Year | 2021 |
| Description | Tuberculosis adherence evidence synthesis and update |
| Organisation | McGill University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | co-I, contribution to protcol and conducting systematic review, paper writing |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | epi; statistics |
| Start Year | 2021 |
| Description | Tuberculosis adherence evidence synthesis and update |
| Organisation | Tufts University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | co-I, contribution to protcol and conducting systematic review, paper writing |
| Collaborator Contribution | Design, implementation and analysis |
| Impact | epi; statistics |
| Start Year | 2021 |
| Description | U-SMRC |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Co-I, steering committee |
| Collaborator Contribution | Design, implementation, parasitology, genetics, immunology |
| Impact | Epidemiology, parasitology, laboratory sciences, immunology, mathematical modelling |
| Start Year | 2022 |
| Description | Use of CPAP in patients hospitalised with Covid |
| Organisation | Calderdale and Huddersfield NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Design and analysis |
| Collaborator Contribution | Specialist Covid clinical expertise, data collection |
| Impact | Paper published. Evolving, further study planned to understand the role of CPAP in frail patients with Covid |
| Start Year | 2020 |
| Description | Using pneumococcal carriage and invasiveness to inform vaccine policy in tropical Africa (CB) |
| Organisation | Kenyan Institute for Medical Research (KEMRI) |
| Country | Kenya |
| Sector | Public |
| PI Contribution | study statistician |
| Collaborator Contribution | design and coordination of the study |
| Impact | no papers yet. Multi-disciplinary: epidemiology, genetics, statistics |
| Start Year | 2019 |
| Description | VAXEF |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Statistician |
| Collaborator Contribution | Design, Implementation |
| Impact | Epidemiology, laboratory sciences |
| Start Year | 2022 |
| Description | VAnguard |
| Organisation | Medical Research Council (MRC) |
| Department | MRC/UVRI and LSHTM Research Unit Uganda |
| Country | Uganda |
| Sector | Academic/University |
| PI Contribution | Co-I, WP co-lead for analysis and modelling |
| Collaborator Contribution | Design, implementation, social science, public engagement |
| Impact | Epidemiology, vaccinology, social science, mathematical modelling, statistics |
| Start Year | 2022 |
| Description | VITALITY |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Lusaka |
| Country | Zambia |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | VITALITY |
| Organisation | University of Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study design, analysis |
| Collaborator Contribution | Study design, implementation and evaluation |
| Impact | Multidisciplinary: clinical medicine, epidemiology, clinical trials, health economics |
| Start Year | 2020 |
| Description | Y-CHECK |
| Organisation | National Institute for Medical Research, Tanzania |
| Department | Mwanza Intervention Trials Unit (MITU) |
| Country | Tanzania, United Republic of |
| Sector | Public |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK |
| Organisation | University of Ghana |
| Country | Ghana |
| Sector | Academic/University |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Co-I |
| Collaborator Contribution | Design & analysis |
| Impact | None yet |
| Start Year | 2023 |
| Description | Y-CHECK |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Study design |
| Collaborator Contribution | Study design, implementation |
| Impact | Multidisciplinary: epidemiology, public health |
| Start Year | 2018 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Biomedical Research and Training Institute (BRTI) |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Government of Zimbabwe |
| Department | Ministry of Primary and Secondary Education |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | Ministry of Health and Child Welfare of the Republic of Zimbabwe |
| Country | Zimbabwe |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | University of Zimbabwe |
| Country | Zimbabwe |
| Sector | Academic/University |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Y-CHECK (Zimbabwe) |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Project lead, study design, analysis |
| Collaborator Contribution | Design, implementation, and analysis |
| Impact | None yet |
| Start Year | 2021 |
| Description | Zvatinoda! |
| Organisation | Organization for Public Health Interventions and Development |
| Country | Zimbabwe |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, project coordination |
| Collaborator Contribution | Study design and coordination, fieldwork, liaison with policy makers, digital intervention expertise |
| Impact | none yet. Multidisciplinary: Epidemiology, social science, implementation science |
| Start Year | 2019 |
| Description | Zvatinoda! |
| Organisation | The SHM Foundation |
| Country | United Kingdom |
| Sector | Charity/Non Profit |
| PI Contribution | Study design, project coordination |
| Collaborator Contribution | Study design and coordination, fieldwork, liaison with policy makers, digital intervention expertise |
| Impact | none yet. Multidisciplinary: Epidemiology, social science, implementation science |
| Start Year | 2019 |
| Title | Eave Tubes |
| Description | Vector control tool which has been evaluated in one CRT; currently searching for funding for a second trial to enable WHO policy decisions |
| Type | Preventative Intervention - Physical/Biological risk modification |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2019 |
| Development Status | Actively seeking support |
| Clinical Trial? | Yes |
| Impact | We have generated the first epidemiological evidence for the combined intervention of Eave Tubes and house screening. We measured a 40% decrease in malaria case incidence in children living in villages where the intervention was installed. This evidence has been published in the Lancet and has been reported to WHO to feed into future policy decisions. |
| Title | Next generation bed nets |
| Description | Bed nets with new active ingredients being trialled in CRT in Benin |
| Type | Preventative Intervention - Physical/Biological risk modification |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2021 |
| Development Status | Under active development/distribution |
| Impact | Trial is still ongoing so no impact so far |
| Title | Yathu-Yathu |
| Description | Community-based sexual health services for adolescents and young people in Zambia. Community-randomised trial funded by MRC. |
| Type | Health and Social Care Services |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2019 |
| Development Status | Under active development/distribution |
| Clinical Trial? | Yes |
| Impact | None yet, trial still in progress. |
| Title | CLAN |
| Description | Command for Stata to conduct a cluster level analysis adjusting for individual level covariates |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Impact | None yet |
| URL | https://ideas.repec.org/c/boc/bocode/s458844.html |
| Title | CRT website |
| Description | A website collating guidance on cluster randomised trials and stepped wedge trials |
| Type Of Technology | Webtool/Application |
| Year Produced | 2022 |
| Impact | None yet |
| URL | https://clusterrandomisedtrials.qmul.ac.uk/ |
| Title | RtD3 |
| Description | An R package for generating interactive visualisations of rt estimates. Provides an interface for the JavaScript library rt_vis. This package was designed using rt estimates generated by the EpiNow2 package, an open source resource for creating rt estimates. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | None yet |
| URL | https://zenodo.org/record/4011842 |
| Title | UK Colocation Dashboard |
| Description | Interactive dashboard of Facebook Colocation data in the UK. |
| Type Of Technology | Software |
| Year Produced | 2020 |
| Open Source License? | Yes |
| Impact | Used by multiple government users as a proxy for differing contact rates in local areas in the UK. Users include: Cabinet Office, Bank of England, Cardiff & Vale NHS Trust. |
| URL | https://cmmid.github.io/colocation_dashboard_cmmid/ |
| Title | pull_facebook_data_for_good |
| Description | Tool to automate data download for researchers using data from Facebook Data for Good. |
| Type Of Technology | Software |
| Year Produced | 2021 |
| Open Source License? | Yes |
| Impact | None yet |
| URL | https://github.com/hamishgibbs/pull_facebook_data_for_good |
| Description | 5th Southern Africa Malaria Research Conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presentation presenting results of CRT on reactive focal malaria elimination interventions in Namibia |
| Year(s) Of Engagement Activity | 2019 |
| Description | AMARI Video |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | ARTICULATE "Filling the Gap" is a mental health documentary which highlights the work of selected AMARI fellows in communities as part of their contributions to cut the huge mental health treatment gap. The film also showcases lived experiences of people living with Mental, Neurological and Substance misuse disorders (MNS). |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.youtube.com/watch?v=b_82Zge0-Lg |
| Description | AMR STI Conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | 2 day conference tp bring together experts working at the interface of AMR and STI research, policy and practice with a view to identifying bottlenecks and solutions for tackling STI AMR and developing short and long term action plans |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/global-local-addressing-threat-amr-sti-control |
| Description | ASTMH conference (JB) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presentation at ASTMH conference |
| Year(s) Of Engagement Activity | 2019 |
| Description | ASTMH: Symposium on PBO Nets |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Symposium on New Generation Long Lasting Insecticide Treated Nets for malaria prevention |
| Year(s) Of Engagement Activity | 2019 |
| Description | Adolescent Health 2019 Coming of Age |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Prof Helen Weiss, oral presentation at Adolescent Health - Coming of age conference held by RCPCH |
| Year(s) Of Engagement Activity | 2019 |
| Description | BBC world service interview |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | BBC World Service interview in response to second recorded case of "cure" from HIV announced at CROI |
| Year(s) Of Engagement Activity | 2019 |
| Description | BMGF Vector trial design |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Oral presentation re. the Eave Tubes trial to trial design and vector control experts to draw consensus of priorities for future trial design |
| Year(s) Of Engagement Activity | 2020 |
| Description | CROI/ ISSTDR/ IAS 2019 |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talks on PopART trial results at CROI, IAS and ISSTDR conferences in 2019 |
| Year(s) Of Engagement Activity | 2019 |
| Description | Covid related interviews |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Radio and TV interviews with BBC for advice related to Covid in early days of epidemic in UK and emergence as a global pandemic |
| Year(s) Of Engagement Activity | 2020 |
| Description | E8 Entomology workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Delivered sessions in a workshop as part of Malaria Elimination Eight Entomology fellowship programme |
| Year(s) Of Engagement Activity | 2023 |
| Description | EDCTP Forum |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Oral presention on ENTRANT at EDCTP Forum. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Ending Period Poverty Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop on ending period poverty by 2030, bringing together researchers, funders, policy makers and practitioners to discuss how to use evidence to develop and deliver menstrual health policies and programmes. |
| Year(s) Of Engagement Activity | 2017,2019 |
| Description | FCDO overview of Malaria Centre |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Supporters |
| Results and Impact | Meeting with FCDO to disseminate work of the malaria Centre and discuss future priorities in malaria research |
| Year(s) Of Engagement Activity | 2023 |
| Description | Feminem Podcast |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Podcast on careers in epidemiology and gender equity in leadership |
| Year(s) Of Engagement Activity | 2019 |
| Description | HAYA Adolescent health research dissemination |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Following the HAYA research programmed in KwaZulu-Natal, South Africa. Young people co-created and performed songs and films to share messages from the research with their peers and other stakeholders. |
| Year(s) Of Engagement Activity | 2019 |
| Description | HIV Webinar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar: HIV prevention cascades: A new tool to strengthen implementation of efficacious HIV prevention methods. In this talk, demographer Simon Gregson: Described the rationale for regular measurement and interpretation of HIV prevention cascades Summarised the development and current thinking on HIV prevention cascade formulations and explanatory frameworks, and Presented findings from recent applications of HIV prevention cascades in Manicaland, Zimbabwe Talk was hosted by LSHTM's STI Research Interest Group which is co-directed by a staff member funded by this award |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/newsevents/events/hiv-prevention-cascades-new-tool-strengthen-implementation... |
| Description | HIV: Diverse challenges among children and women in Asia and Africa |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | HIV: Diverse challenges among children and women in Asia and Africa - talk by Dr Fatima Mir (The Aga Khan University, Pakistan) and Prof Gita Ramjee (The Aurum Foundation, South Africa) hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/webinar-hiv-diverse-challenges-among-children-and-women-as... |
| Description | IAS 2018 (KS) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Evaluating uptake of anti-retroviral treatment irrespective of CD4 count |
| Year(s) Of Engagement Activity | 2018 |
| Description | IBS-SSACAB joint conference |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | chaired 1-hour session at IBS-SSACAB Joint conference Cape Town |
| Year(s) Of Engagement Activity | 2019 |
| Description | IBS-SSACAB joint conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | conference talk |
| Year(s) Of Engagement Activity | 2020 |
| Description | INTERTB symposium presentation |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited oral presentation at the INTERTB symposium, St George's University. |
| Year(s) Of Engagement Activity | 2023 |
| Description | ISCB conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Study participants or study members |
| Results and Impact | Presentation on measuring repeatability of titration assays |
| Year(s) Of Engagement Activity | 2023 |
| Description | ISEG 50th Symposium |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | ISEG celebrated its 50th anniversary by hosting a virtual symposium with six partner institutes in Colombia (CIDEIM), The Gambia (MRC Unit The Gambia at LSHTM), Tanzania (Mwanza Intervention Trials Unit), Uganda (MRC/UVRI and LSHTM Uganda Research Unit), Zambia (Zambart) and Zimbabwe (The Health Research Unit). The symposium was a 3-day event with over 800 people registered and between 100-250 attendees per session. The symposium hosted scientific talks from each of the partner institutes on a wide range of infectious and non-communicable diseases, including COVID-19 surveillance and universal HIV testing and treatment. The central theme of the symposium was expanding capacity in medical statistics in lower income countries; survey results were presented on the barriers and facilitators of capacity strengthening in medical statistics, and we interviewed participants involved in several different capacity strengthening/training schemes at MRC Unit The Gambia at LSHTM, The Health Research Unit in Zimbabwe and Zambart, Zambia. Overall, the symposium struck a chord with participants around the need for increasing capacity in medical statistics for global health. Half of the participants who responded to the symposium evaluation survey said they planned to implement or change capacity strengthening activities as a result of the symposium, and 55% gave their names as potential mentors for future activities. The results of the symposium capacity strengthening survey were used to inform a future grant application. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/research/centres-projects-groups/mrc-international-statistics-and-epidemiolo... |
| Description | Immunisation and adolescents - the HPV vaccine |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Speaker discussed where we are at this point with the HPV vaccine programs nationally and globally and what impact we can already see. Event finished with a discussion about attitudes towards the vaccine and how we should deal with potential shortages, as have recently arisen. The event was co-hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/immunisation-and-adolescents-hpv-vaccine |
| Description | Imperial University invited talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | International Papilloma Virus |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Talk on results of immunobriding study of HPV vaccine |
| Year(s) Of Engagement Activity | 2021 |
| Description | Interview about COVID-19 study |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | Interview published in sciencenews.dk on a study reporting on the characteristics of the BA.5 subvariant versus previous Omicron subvariants. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://sciencenews.dk/en/analysis-of-ba5-versus-previous-omicron-subvariants |
| Description | Joint WHO-Wageningen University of Research Global Vector Control Response conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Oral Presentation on Insecticides and Malaria Control |
| Year(s) Of Engagement Activity | 2019 |
| Description | Ke Mo Leseding (Into the light), combatting HIV/AIDS stigma in Botswana with innovative approaches |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This event screened Ke Mo Leseding (Into the light), a film about an intimate and inspirational journey that outlines the story of Stanley Monageng, a 72 year old HIV activist. A message to the people of Botswana, the film tells the story of Stanley's determination to walk over 370 kilometres in just eleven days to provide HIV/AIDS education to the most remote parts of the country. The film featured testament from HIV activists, doctors, political leaders, and community members all pleading Batswana to test and treat for HIV and was followed by a Q&A session with Stanley and the filmmakers. Event hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/ke-mo-leseding-light-combatting-hivaids-stigma-botswana-in... |
| Description | King College invited seminar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | Malaria Centre biannual brochure |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | A brochure highlighting the work of the Malaria Centre at LSHTM. The report was launched with a talk at ASTMH in Seattle. The report is also available online. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/research/centres/malaria-centre |
| Description | Malaria and Climate Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Postgraduate students |
| Results and Impact | Malaria Modelling and Analytics: Leaders in Africa (MMALA): workshop at University of Cape Town |
| Year(s) Of Engagement Activity | 2023 |
| Description | Media interviews around release of primary results of PopART trial |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Media (as a channel to the public) |
| Results and Impact | Media interviews around the publication of the primary results of the PopART trial |
| Year(s) Of Engagement Activity | 2019 |
| Description | Mental Health World Congress News |
| Form Of Engagement Activity | A magazine, newsletter or online publication |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Interview in Mental Health World Congress Magazine about menstrual health research in the context of school mental health and school drop out |
| Year(s) Of Engagement Activity | 2019 |
| Description | Neisseria gonorrhoeae genomics and antibiotic resistance |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Neisseria gonorrhoeae genomics and antibiotic resistance webinar given by Dr Yonatan Grad (Harvard T.H. Chan) hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/webinar-neisseria-gonorrhoeae-genomics-and-antibiotic-resi... |
| Description | Networking Breakfast |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | TEG networking breakfast at LSHTM - approx 20 LSHTM staff attended a talk designed to promote TEG's work and encourage new collaborations |
| Year(s) Of Engagement Activity | 2019 |
| Description | PANGEA consortium workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Meeting with UNAIDS/WHO and other internatioal agencies to discuss implications of PopART and PANGEA findings or global HIV policy. |
| Year(s) Of Engagement Activity | 2023 |
| Description | PIP/AHRI Data workshop |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Longitudinal nature of data, data collection approach utilized, how to merge such datasets with hospital records of mortalit and also proposed methods of analysis were presented and participants had practical sessions using Stata or R (as per their choice). The purpose was to enabling participants to work on Africa Health Research Institute Population Intervention Programme (PIP) datasets. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Panel at VCWG |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Panel discussion about the future of bed nets at the Roll back Malaria vector control working group meeting in Accra, Ghana |
| Year(s) Of Engagement Activity | 2023 |
| Description | PhD student showcase day for Malaria Centre |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | I organised a PhD showcase day where PhD and MSc students could present their work and receive feedback- part of my role as co-Director of the Malaria Centre |
| Year(s) Of Engagement Activity | 2022 |
| Description | Pint of Science (SN) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Public/other audiences |
| Results and Impact | Public talk about trial in Uganda and South Africa, as part of national science festival |
| Year(s) Of Engagement Activity | 2019 |
| Description | PopART and UTT |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk at Francis Crick Institute for World AIDS Day 2019 |
| Year(s) Of Engagement Activity | 2019 |
| Description | PopART talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Lecture given to participants in Symposium on CRTs at Queen Mary University of London |
| Year(s) Of Engagement Activity | 2021 |
| Description | Principles of Epi and Stats short course |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | 2 weeks of full time teaching in principles of epidemiology and statistics for research staff at THRU-Zim and the UZ Clinical Trials Unit. I organised the course and did some of the teaching |
| Year(s) Of Engagement Activity | 2023 |
| Description | Programmatic considerations for integrating STI services into pre-exposure prophylaxis (PrEP) programmes |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Dr Jason Ong (Monash University and University of Melbourne) gave a talk on the high prevalence and incidence of sexually transmitted infections (STI) among PrEP users, and how as PrEP programmes continue to be scaled up globally, how many have integrated STI testing into their PrEP programs, and what challenges remain for implementers? Event hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/programmatic-considerations-integrating-sti-services-pre-e... |
| Description | Punishing the prostitute and protecting the soldier: the Lal Bazaar, lock hospital and the treatment of venereal disease in colonial India |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk by Dr Erica Wald, Goldsmiths. The British Army in India had a serious and enduring problem with venereal disease. At any given point across the nineteenth century, roughly 25% of its European troops were in hospital, with some form of what were known as 'vice'-related illnesses, the most frequently diagnosed of which was syphilis. In response to this, medical and commanding offers joined forces to construct a punitive treatment system which targeted the women seen to be the root cause of this problem - those Indian women deemed to be 'common prostitutes'. However, the system continually failed to accomplish any of its aims.The talk explored the construction, operation and consequences of the ways in which syphilis was approached in the nineteenth century. Hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/punishing-prostitute-and-protecting-soldier-lal-bazaar-loc... |
| Description | QMUL CRT conference |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Presented work on malaria CRT design |
| Year(s) Of Engagement Activity | 2023 |
| Description | Quantitative analysis workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | 3 day training course |
| Year(s) Of Engagement Activity | 2023 |
| Description | RSS conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | ISEG symposium given at RSS conference, with speakers Emily Webb, Schadrac Agbla, Paul Mee, Neal Alexander |
| Year(s) Of Engagement Activity | 2021 |
| Description | SADC E8 Webinar |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Professional Practitioners |
| Results and Impact | Inaugural Webinar of SADC Malaria Elimonation Eight: Talk on impact of malaria border health posts |
| Year(s) Of Engagement Activity | 2020 |
| Description | SARS-CoV-2 reinfection study |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview by phone with NPR News, Washington, DC on the interpretation of the SARS-CoV-2 reinfection study |
| Year(s) Of Engagement Activity | 2021 |
| Description | STI Vaccine Workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Workshop on the need for STI vaccines/bottlenecks for development & implementation, bringing together researchers, policy makers and clinicians |
| Year(s) Of Engagement Activity | 2019 |
| URL | https://www.lshtm.ac.uk/newsevents/events/sti-vaccine-workshop-innovations-impact |
| Description | STI co-endemicity and the role of point of care tests for resistance guided therapy |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | This seminar discussed the outcomes of the 'Precise' study, which aimed to develop point of care antimicrobial resistance tests for Neisseria gonorrhoeae and Mycoplasma genitalium infection to ensure accurate resistance guided therapy and antibiotic stewardship in sexual health medicine. Data also presented from a sub-study looking at STI co-infections, macrolide resistance and risk factors associated with MG infection. The talk was hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/sti-co-endemicity-and-role-point-care-tests-resistance-gui... |
| Description | SUSAN-SSACAB conference |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Six previous TEG fellows attended, presented abstracts & discussed to strengthen the network, to share expertise, collaborate on common projects. Also contributed to discussions on how TEG can contribute to the SSACAB initiative for capacity building in SSA |
| Year(s) Of Engagement Activity | 2019 |
| Description | Seminar "Interpretation (and mis-interpretation) of p-values" |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Other audiences |
| Results and Impact | talk as part of monthly seminar series for research community associated with MRC Uganda. |
| Year(s) Of Engagement Activity | 2020 |
| Description | Single-Dose HPV Vaccine Evaluation Consortium |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | member of advisory group |
| Year(s) Of Engagement Activity | 2020 |
| Description | Stepped wedge/cluster randomised trials short course |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Short course on stepped wedge and cluster randomised trials |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/study/courses/short-courses/cluster-randomised-trials |
| Description | Stockholm Convention DDT Expert Group |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Advise the Conference of the Parties to the Stockholm Convention on continued use of DDT for malaria vector control |
| Year(s) Of Engagement Activity | 2020 |
| Description | Talk on MENISCUS study |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Other audiences |
| Results and Impact | Invited speaker for International Women's Day 2022 at the Aberdeen Centre for Women's Health Research |
| Year(s) Of Engagement Activity | 2022 |
| Description | Talk on SARS-CoV-2 variant severity over time |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Other audiences |
| Results and Impact | Health data interest group seminar at LSHTM led by the electronic health records group. Talk given to describe the changing severity of SARS-CoV-2 variants over time in the UK. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Talks on PopART trial results |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talks on PopART trial results given at University of Third Age, Francis Crick Institute and other organizations |
| Year(s) Of Engagement Activity | 2019 |
| Description | Television Interview on ENCA, South Africa |
| Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Public/other audiences |
| Results and Impact | Interview during Evening News on South Africa's main news channel (ENCA) on results of malaria trial in Namibia |
| Year(s) Of Engagement Activity | 2020 |
| Description | The Behaviour Insights Team stepped wedge trial talk |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Professional Practitioners |
| Results and Impact | Invited seminar at a social purpose company part owned by the cabinet office to promote good trial methodology |
| Year(s) Of Engagement Activity | 2019 |
| Description | The elimination of cervical cancer should not be a dream but critical basic elements are still needed |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk byDr Silvia de Sanjosé, US National Cancer Institute. Talk summary: Recently WHO has launched a call to eliminate cervical cancer globally during this century. The joint impact of HPV vaccines and adequate cervical cancer screening and treatment are the pillars for this announcement. The reality is, however, surprisingly behind. Less that 15% of women in LMIC have ever had a screening test and still the majority of girls in the world have not yet been vaccinated. Further, many women living with HIV in low and middle income countries (LMIC) are not receiving an optimal screening approach. Limiting screening to 1 or 2 visits lifetime requires a highly accurate approaches still largely unavailable. Recent scientific developments on the impact of HPV type specific infections and on the use of artificial intelligence based methods to evaluate cervical images in the screening setting open new realistic venues. Talk hosted by STIRIG (LSHTM'S STI Research Interest Group, which is co-directed by ISEG members) Speaker Dr Silvia de Sanjosé, MD and PhD from LSHTM, is a senior Consultant at the US National Cancer Institute (NCI) |
| Year(s) Of Engagement Activity | 2020 |
| URL | https://www.lshtm.ac.uk/newsevents/events/elimination-cervical-cancer-should-not-be-dream-critical-b... |
| Description | Training course Ado Health Epi - ISEG 50th Symposium |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Training webinar 'Introduction to adolescent health epidemiology' held in June 22 as part of the ISEG 50th Symposium. Session was an introduction to the topic with a live Q and A session afterwards. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Training course CRTs - ISEG 50th Symposium |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Training webinar 'Key concepts of cluster randomized trials' held in May 22 as part of the ISEG 50th Symposium. Session was an introduction to the topic with a live Q and A session afterwards. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Training course Outbreak Modelling - ISEG 50th Symposium |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Training webinar 'Introduction to outbreak modelling' held in June 22 as part of the ISEG 50th Symposium. Session was an introduction to the topic with a live Q and A session afterwards. |
| Year(s) Of Engagement Activity | 2022 |
| Description | Video entitled "Widely-used kidney function tests underestimate scale of kidney disease in Africa" publicising the ARK consortium and kidney research published in Lancet Global Health in summer 2022 |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | Awareness of kidney disease burden in SSA |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.youtube.com/watch?v=elEpmwyC4hs&ab_channel=WitsUniversityOFFICIAL |
| Description | WHO DAT Task force |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO Digital Adherence Technology Task force for TB. |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO Malariogenic potential |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Other audiences |
| Results and Impact | WHO Expert Review Group re Malariogenic potential: stratification after elimination- invited expert |
| Year(s) Of Engagement Activity | 2019 |
| Description | WHO VCAG |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | WHO Vector Control Advisory Group |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO VCAG |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO Vector Control Advisory Group |
| Year(s) Of Engagement Activity | 2020 |
| Description | WHO Workshop on PHSM |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | Decide on requiremnts for future research on PHSMs |
| Year(s) Of Engagement Activity | 2023 |
| Description | WHO/UNAIDS/UT3C |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Policymakers/politicians |
| Results and Impact | WHO/UNAIDS consultation with UTT trial investigators to discuss policy implications of trials of universal testing and treatment for HIV |
| Year(s) Of Engagement Activity | 2019 |
| Description | Webinar - Advancing vaccine development for gonorrhoea and the Global STI Vaccine Roadmap |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Hosted a webinar with an invited speaker from the World Health Organisation to give a talk on the Global STI Vaccine Roadmap produced by the WHO, discussing the increasing importance of devveloping STI vaccines given the rising threat of antimicrobial resistance (AMR), particularly in the context of gonorrhoea. The talk was followed by questions and discussions on the importance of surveillance and better quantification of the magnitude of gonorrhoea-associated disease burden, and how to inform decision making about future vaccine policy and programs. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/advancing-vaccine-development-gonorrhoea-and-global-sti-va... |
| Description | Webinar - Global prevalence of syphilis among men who have sex with men (MSM) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Hosted a webinar by Dr Moto Tsuboi (National Center for Global Health and Medicine, Tokyo) on work performed at LSHTM to conduct a global systematic review and meta-analysis for syphilis prevalence among MSM between 2000 and 2020. The findings presented unacceptably high global syphilis prevalence among MSM. Sustained commitment to interventions that can accelerate syphilis prevention, screening, and treatment in this population is urgently needed even in the COVID-19 pandemic. The World Health Organization Global Health Sector Strategy aims to reduce worldwide syphilis incidence by 90% between 2018 and 2030. To achieve this goal, interventions that target high-burden groups, including MSM, will be required. However, there are no global prevalence estimates of syphilis among MSM to serve as a baseline for monitoring or modelling disease burden. Following the talk there was discussion on the importance of surveillance and prevalence estimates and how this could be funded/effected. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/global-prevalence-syphilis-among-men-who-have-sex-men-msm |
| Description | Webinar - Partner notification and treatment: The overlooked steps to combatting the sexually transmitted diseases (STI) epidemic |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Talk from an invited speaker (Dr Pooja Chitneni from Harvard) about her work on partner notification for STIs in South Africa and Uganda. While most STI guidelines recommend STI partner notification and treatment as an integral part of STI care, little is known about how best to support people with STIs to engage their sexual partners. Following the talk questions and discussions took place on how to advance partner notification methods. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/partner-notification-and-treatment-overlooked-steps-combat... |
| Description | Webinar - Schistosomiasis, HIV and women - the role of the cervicovaginal environment and sexually transmitted infection co-infection |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Hosted a webinar by Dr Amy Sturt, a former PhD student of our group now working at Stanford, to give a talk on work conducted whilst at LSHTM on vaginal inflammation, STI co-infection, and the cervicovaginal microbiota as potential co-factors in the association of genital schistosomiasis with HIV-1. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/schistosomiasis-hiv-and-women-role-cervicovaginal-environm... |
| Description | Webinar - Testing for sexually transmitted infections (STIs) in Zimbabwe: Who, where, when and how? |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar: Testing for sexually transmitted infections (STIs) in Zimbabwe: Who, where, when and how? Effective STI control is a key priority in low and middle-income countries, where syndromic management is currently the standard of care. This is especially relevant in regions of high STI/HIV prevalence. Newer STI diagnostics integrated into HIV, Antenatal Care or Sexual and Reproductive Health services may provide a feasible and cost-effective solution. This talk summarises findings from completed/ongoing and planned studies aimed at evaluating STI testing approaches in community and facility settings in Zimbabwe. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/newsevents/events/testing-sexually-transmitted-infections-stis-zimbabwe-who-... |
| Description | Webinar - WHO guidelines for the management of symptomatic sexually transmitted infections (STIs) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | We hosted a webinar by Dr Teodora Wi of the World Health Organisation, providing an in depth presentation on the new WHO guidelines for the management of symptomatic sexually transmitted infections (STIs) followed by a Q&A session from the audience. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/who-guidelines-management-symptomatic-sexually-transmitted... |
| Description | Webinar - interview with Ina Park, author of Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDs |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar hosted by LSHTM's STI Research Interest Group, STIRIG, which is co-directed by an ISEG member. The author of "Strange Bedfellows", a book about the history, science and impact of STIs was interviewed with subsequent Q&A from the audience, with a strong focus on the impact of stigma. Discussion afterwards led to discussions with BASHH (British Association of Sexual Health & HIV) on how to work together to better promote careers in sexual health and inform, educate and de-stigmatise on STIs. |
| Year(s) Of Engagement Activity | 2021 |
| URL | https://www.lshtm.ac.uk/newsevents/events/interview-ina-park-author-strange-bedfellows-adventures-sc... |
| Description | Webinar on STIs |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | Webinar: Sexually transmitted infection (STI) trends in the first year of the COVID-19 pandemic in the UK This webinar featured key speakers from the UK Health Services Agency, speaking about: The impact of COVID-19 on sexual risk behaviour, service use and STI testing of young people in England The impact of the COVID-19 pandemic on sexual health service utilisation by men who have sex with men (MSM) in England Ethnic variations in sexual risk behaviour, sexual health service use and unmet need during the first year of the COVID-19 pandemic Webinar organised and hosted by LSHTM's STI Research Interest Group, co-directed by a member of staff funded in part from this award. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/newsevents/events/sexually-transmitted-infection-sti-trends-first-year-covid... |
| Description | Webinar: Mentorship in the field of sexually transmitted infections (STIs) |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | ISEG organised webinar on mentorship experiences in the field of sexually transmitted infections, successful mentorship programmes conducted outside of this field that may be modified to support the next generation of STI researchers, and valuable concepts in mentoring relationships. This talk will included a facilitated discussion around the factors and approaches useful in an STI mentorship programme. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/newsevents/events/mentorship-field-sexually-transmitted-infections-stis |
| Description | Webinar: Monkeypox - an emerging sexually transmitted infection? |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | ISEG organised webinar in which Dr Michael Marks discussed the current epidemic of monkeypox and highlighted key findings in terms of our current understanding of the transmission of monkeypox within sexual networks. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://www.lshtm.ac.uk/newsevents/events/monkeypox-emerging-sexually-transmitted-infection |